0001682325--12-312021Q1GTY Technology Holdings Inc.00falseP1Y3M19DP2Y0001682325gtyhu:PublicWarrantsMember2021-03-310001682325gtyhu:PrivateWarrantsMember2021-03-310001682325gtyhu:PublicWarrantsMember2020-12-310001682325gtyhu:EcivisAcquisitionMembergtyhu:RedeemableCommonStockMember2019-06-012019-06-300001682325gtyhu:EcivisAcquisitionMembergtyhu:AdditionalCommonStockMember2019-06-012019-06-300001682325gtyhu:QuesticaAndBonfireMembergtyhu:ExchangeableSharesMember2021-01-012021-03-310001682325us-gaap:TreasuryStockMember2021-03-310001682325us-gaap:RetainedEarningsMember2021-03-310001682325us-gaap:AdditionalPaidInCapitalMember2021-03-310001682325us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-03-310001682325srt:ScenarioPreviouslyReportedMemberus-gaap:TreasuryStockMember2020-12-310001682325srt:ScenarioPreviouslyReportedMemberus-gaap:RetainedEarningsMember2020-12-310001682325srt:ScenarioPreviouslyReportedMemberus-gaap:AdditionalPaidInCapitalMember2020-12-310001682325srt:ScenarioPreviouslyReportedMemberus-gaap:AccumulatedOtherComprehensiveIncomeMember2020-12-310001682325srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMemberus-gaap:RetainedEarningsMember2020-12-310001682325srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMemberus-gaap:AdditionalPaidInCapitalMember2020-12-310001682325us-gaap:TreasuryStockMember2020-12-310001682325us-gaap:RetainedEarningsMember2020-12-310001682325us-gaap:AdditionalPaidInCapitalMember2020-12-310001682325us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-12-310001682325srt:ScenarioPreviouslyReportedMember2020-12-310001682325srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember2020-12-310001682325us-gaap:TreasuryStockMember2020-03-310001682325us-gaap:RetainedEarningsMember2020-03-310001682325us-gaap:AdditionalPaidInCapitalMember2020-03-310001682325us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-03-310001682325srt:ScenarioPreviouslyReportedMemberus-gaap:TreasuryStockMember2019-12-310001682325srt:ScenarioPreviouslyReportedMemberus-gaap:RetainedEarningsMember2019-12-310001682325srt:ScenarioPreviouslyReportedMemberus-gaap:AdditionalPaidInCapitalMember2019-12-310001682325srt:ScenarioPreviouslyReportedMemberus-gaap:AccumulatedOtherComprehensiveIncomeMember2019-12-310001682325srt:RestatementAdjustmentMemberus-gaap:RetainedEarningsMember2019-12-310001682325srt:RestatementAdjustmentMemberus-gaap:AdditionalPaidInCapitalMember2019-12-310001682325us-gaap:TreasuryStockMember2019-12-310001682325us-gaap:RetainedEarningsMember2019-12-310001682325us-gaap:AdditionalPaidInCapitalMember2019-12-310001682325us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-12-310001682325srt:ScenarioPreviouslyReportedMember2019-12-310001682325srt:RestatementAdjustmentMember2019-12-310001682325us-gaap:CommonStockMember2021-03-310001682325gtyhu:ExchangeableSharesMember2021-03-310001682325srt:ScenarioPreviouslyReportedMemberus-gaap:CommonStockMember2020-12-310001682325srt:ScenarioPreviouslyReportedMembergtyhu:ExchangeableSharesMember2020-12-310001682325us-gaap:CommonStockMember2020-12-310001682325gtyhu:ExchangeableSharesMember2020-12-310001682325us-gaap:CommonStockMember2020-03-310001682325gtyhu:ExchangeableSharesMember2020-03-310001682325srt:ScenarioPreviouslyReportedMemberus-gaap:CommonStockMember2019-12-310001682325srt:ScenarioPreviouslyReportedMembergtyhu:ExchangeableSharesMember2019-12-310001682325us-gaap:CommonStockMember2019-12-310001682325gtyhu:ExchangeableSharesMember2019-12-310001682325us-gaap:StockOptionMember2021-01-012021-03-310001682325us-gaap:StockOptionMember2020-01-012020-12-310001682325us-gaap:StockOptionMember2021-03-310001682325us-gaap:StockOptionMember2020-12-310001682325us-gaap:PerformanceSharesMember2021-01-012021-03-310001682325srt:MinimumMemberus-gaap:RestrictedStockUnitsRSUMemberus-gaap:ShareBasedCompensationAwardTrancheOneMember2021-01-012021-03-310001682325srt:MaximumMemberus-gaap:RestrictedStockUnitsRSUMemberus-gaap:ShareBasedCompensationAwardTrancheOneMember2021-01-012021-03-310001682325us-gaap:RestrictedStockUnitsRSUMemberus-gaap:ShareBasedCompensationAwardTrancheTwoMember2021-01-012021-03-310001682325srt:MinimumMember2021-03-310001682325us-gaap:SubscriptionAndCirculationMember2021-01-012021-03-310001682325us-gaap:LicenseMember2021-01-012021-03-310001682325gtyhu:ProfessionalServicesMember2021-01-012021-03-310001682325gtyhu:AssetSalesMember2021-01-012021-03-310001682325us-gaap:SubscriptionAndCirculationMember2020-01-012020-03-310001682325us-gaap:LicenseMember2020-01-012020-03-310001682325gtyhu:ProfessionalServicesMember2020-01-012020-03-310001682325gtyhu:SherpaMembergtyhu:PaycheckProtectionProgramMember2020-04-012020-05-310001682325gtyhu:EcivisMembergtyhu:PaycheckProtectionProgramMember2020-04-012020-05-310001682325gtyhu:CitybaseMembergtyhu:PaycheckProtectionProgramMember2020-04-012020-05-310001682325gtyhu:AtMarketOfferingMember2021-01-012021-03-310001682325us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-012021-03-310001682325us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-01-012020-03-310001682325us-gaap:RetainedEarningsMember2021-01-012021-03-310001682325us-gaap:RetainedEarningsMember2020-01-012020-03-310001682325us-gaap:NoncompeteAgreementsMember2021-03-310001682325us-gaap:CustomerRelationshipsMember2021-03-310001682325gtyhu:TradeNamesAndTradeMarksMember2021-03-310001682325gtyhu:PatentsAndDevelopmentTechnologyMember2021-03-310001682325us-gaap:NoncompeteAgreementsMember2020-12-310001682325us-gaap:CustomerRelationshipsMember2020-12-310001682325gtyhu:TradeNamesAndTradeMarksMember2020-12-310001682325gtyhu:PatentsAndDevelopmentTechnologyMember2020-12-310001682325gtyhu:WarrantLiabilityMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2021-03-310001682325gtyhu:ContingentConsiderationNonCurrentMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2021-03-310001682325gtyhu:ContingentConsiderationCurrentMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2021-03-310001682325us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2021-03-310001682325gtyhu:WarrantLiabilityMemberus-gaap:FairValueMeasurementsRecurringMember2021-03-310001682325gtyhu:ContingentConsiderationNonCurrentMemberus-gaap:FairValueMeasurementsRecurringMember2021-03-310001682325gtyhu:ContingentConsiderationCurrentMemberus-gaap:FairValueMeasurementsRecurringMember2021-03-310001682325us-gaap:FairValueMeasurementsRecurringMember2021-03-310001682325gtyhu:WarrantLiabilityMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2020-12-310001682325gtyhu:ContingentConsiderationNonCurrentMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2020-12-310001682325gtyhu:ContingentConsiderationCurrentMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2020-12-310001682325us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2020-12-310001682325gtyhu:WarrantLiabilityMemberus-gaap:FairValueMeasurementsRecurringMember2020-12-310001682325gtyhu:ContingentConsiderationNonCurrentMemberus-gaap:FairValueMeasurementsRecurringMember2020-12-310001682325gtyhu:ContingentConsiderationCurrentMemberus-gaap:FairValueMeasurementsRecurringMember2020-12-310001682325us-gaap:FairValueMeasurementsRecurringMember2020-12-310001682325us-gaap:RestrictedStockUnitsRSUMember2021-03-310001682325gtyhu:PaycheckProtectionProgramMember2020-04-012020-05-310001682325gtyhu:November2020CreditFacilityMemberus-gaap:LondonInterbankOfferedRateLIBORMember2021-03-310001682325gtyhu:November2020CreditFacilityMemberus-gaap:LondonInterbankOfferedRateLIBORMember2020-11-130001682325gtyhu:PaycheckProtectionProgramMember2021-03-310001682325gtyhu:November2020CreditFacilityMember2020-11-130001682325gtyhu:SherpaMembergtyhu:PaycheckProtectionProgramMember2021-01-012021-03-310001682325us-gaap:SubscriptionAndCirculationMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:RevenueFromRightsConcentrationRiskMember2021-01-012021-03-310001682325us-gaap:LicenseMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:RevenueFromRightsConcentrationRiskMember2021-01-012021-03-310001682325srt:NorthAmericaMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:RevenueFromRightsConcentrationRiskMember2021-01-012021-03-310001682325gtyhu:ProfessionalServicesMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:RevenueFromRightsConcentrationRiskMember2021-01-012021-03-310001682325gtyhu:AssetsSaleMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:RevenueFromRightsConcentrationRiskMember2021-01-012021-03-310001682325us-gaap:SubscriptionAndCirculationMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:RevenueFromRightsConcentrationRiskMember2020-01-012020-03-310001682325us-gaap:LicenseMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:RevenueFromRightsConcentrationRiskMember2020-01-012020-03-310001682325gtyhu:ProfessionalServicesMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:RevenueFromRightsConcentrationRiskMember2020-01-012020-03-310001682325gtyhu:AssetsSaleMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:RevenueFromRightsConcentrationRiskMember2020-01-012020-03-310001682325srt:ScenarioPreviouslyReportedMembergtyhu:ReclassificationOfWarrantsAsLiabilitiesMember2020-01-012020-03-310001682325srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMembergtyhu:ReclassificationOfWarrantsAsLiabilitiesMember2020-01-012020-03-310001682325us-gaap:CommonClassAMember2021-03-310001682325gtyhu:AtMarketOfferingMember2020-11-2500016823252020-03-3100016823252019-12-310001682325us-gaap:FairValueInputsLevel3Member2021-03-310001682325us-gaap:FairValueInputsLevel3Member2020-12-310001682325us-gaap:FairValueInputsLevel3Member2021-01-012021-03-310001682325gtyhu:EcivisAcquisitionMembergtyhu:RedeemableCommonStockMember2019-02-192019-02-190001682325gtyhu:EcivisAcquisitionMember2019-02-192019-02-190001682325us-gaap:CorporateMember2021-03-310001682325gtyhu:PermittingMember2021-03-310001682325us-gaap:CorporateMember2020-12-310001682325gtyhu:ProcurementMember2020-12-310001682325gtyhu:PermittingMember2020-12-310001682325gtyhu:PaymentsMember2020-12-310001682325gtyhu:GrantsManagementMember2020-12-310001682325gtyhu:BudgetMember2020-12-310001682325us-gaap:WarrantMember2021-01-012021-03-310001682325us-gaap:RestrictedStockUnitsRSUMember2021-01-012021-03-310001682325us-gaap:EmployeeStockOptionMember2021-01-012021-03-310001682325us-gaap:WarrantMember2020-01-012020-03-310001682325us-gaap:RestrictedStockUnitsRSUMember2020-01-012020-03-310001682325us-gaap:EmployeeStockOptionMember2020-01-012020-03-310001682325gtyhu:ProcurementMember2021-01-012021-03-310001682325gtyhu:PermittingMember2021-01-012021-03-310001682325gtyhu:BudgetMember2021-01-012021-03-310001682325gtyhu:PermittingMember2020-01-012020-03-310001682325gtyhu:GrantsManagementMember2020-01-012020-03-310001682325gtyhu:BudgetMember2020-01-012020-03-310001682325gtyhu:November2020CreditFacilityMember2020-01-012020-03-310001682325us-gaap:RestrictedStockUnitsRSUMember2021-01-012021-03-310001682325us-gaap:RestrictedStockUnitsRSUMember2020-01-012020-03-310001682325srt:ScenarioPreviouslyReportedMembergtyhu:ReclassificationOfWarrantsAsLiabilitiesMember2020-12-310001682325srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMembergtyhu:ReclassificationOfWarrantsAsLiabilitiesMember2020-12-310001682325us-gaap:AdditionalPaidInCapitalMember2021-01-012021-03-310001682325gtyhu:ExchangeableSharesMember2021-01-012021-03-310001682325us-gaap:CommonStockMember2021-01-012021-03-310001682325gtyhu:EcivisAcquisitionMembergtyhu:AdditionalCommonStockMember2019-02-192019-02-1900016823252020-03-202020-03-200001682325gtyhu:ProcurementMember2021-03-310001682325gtyhu:PaymentsMember2021-03-310001682325gtyhu:GrantsManagementMember2021-03-310001682325gtyhu:BudgetMember2021-03-310001682325us-gaap:CorporateMember2021-01-012021-03-310001682325gtyhu:PaymentsMember2021-01-012021-03-310001682325gtyhu:GrantsManagementMember2021-01-012021-03-310001682325us-gaap:CorporateMember2020-01-012020-03-310001682325gtyhu:ProcurementMember2020-01-012020-03-310001682325gtyhu:PaymentsMember2020-01-012020-03-3100016823252020-02-012020-02-2900016823252019-06-012019-06-3000016823252020-12-310001682325us-gaap:CommonStockMember2020-01-012020-03-310001682325gtyhu:ExchangeableSharesMember2020-01-012020-03-310001682325gtyhu:February2020CreditFacilityMember2020-02-140001682325gtyhu:PaycheckProtectionProgramMember2021-01-012021-03-310001682325gtyhu:November2020CreditFacilityMember2021-01-012021-03-310001682325gtyhu:November2020CreditFacilityMember2020-11-132020-11-130001682325gtyhu:November2020CreditFacilityMember2021-03-3100016823252021-03-310001682325gtyhu:February2020CreditFacilityMember2020-02-142020-02-140001682325gtyhu:EcivisAcquisitionMember2019-02-190001682325gtyhu:AtMarketOfferingMember2020-11-252020-11-250001682325us-gaap:TreasuryStockMember2021-01-012021-03-310001682325us-gaap:AdditionalPaidInCapitalMember2020-01-012020-03-3100016823252020-01-012020-03-3100016823252021-05-1300016823252021-01-012021-03-31xbrli:sharesiso4217:USDiso4217:USDxbrli:sharesxbrli:puregtyhu:segment

Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2021

OR

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from            to

GTY TECHNOLOGY HOLDINGS INC.

(Exact name of registrant as specified in its charter)

Massachusetts

001-37931

83-2860149

(State or other jurisdiction of incorporation)

(Commission File Number)

(IRS Employer Identification No.)

1180 North Town Center Drive, Suite 100, Las Vegas, Nevada 89144

(Address of principal executive offices, including zip code)

Registrant’s telephone number, including area code: (702) 945-2898

Not Applicable

(Former name or former address, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

    

Trading Symbol(s)

    

Name of each exchange on which registered

 

 

 

 

 

Common Stock, par value $0.0001 per share

 

GTYH

 

Nasdaq Stock Market LLC

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes   No  

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes   No  

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer

Accelerated filer

Non-accelerated filer

Smaller reporting company

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No 

As of May 13, 2021, 57,495,291 shares of common stock, par value $0.0001 per share were outstanding.

Table of Contents

GTY TECHNOLOGY HOLDINGS INC.

Form 10-Q

For the Quarter Ended March 31, 2021

Table of Contents

    

Page No.

PART I. FINANCIAL INFORMATION

Item 1.

Financial Statements

3

Unaudited Condensed Consolidated Balance Sheets

3

Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss

4

Unaudited Condensed Consolidated Statements of Changes in Shareholders’ Equity

5

Unaudited Condensed Consolidated Statements of Cash Flows

6

Notes to Unaudited Condensed Consolidated Financial Statements

8

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

23

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

34

Item 4.

Controls and Procedures

34

PART II. OTHER INFORMATION

35

Item 1.

Legal Proceedings

35

Item 1A.

Risk Factors

35

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

35

Item 6.

Exhibits

36

2

Table of Contents

PART I - FINANCIAL INFORMATION

Item 1. Financial Statements

GTY TECHNOLOGY HOLDINGS INC.

CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)

(Amounts in thousands)

March 31, 

December 31, 

    

2021

  

2020

Assets

 

  

 

  

Current assets:

 

  

 

  

Cash and cash equivalents

$

17,936

$

22,800

Accounts receivable, net

10,752

9,994

Prepaid expenses and other current assets

 

3,855

 

2,583

Total current assets

 

32,543

 

35,377

 

 

Property and equipment, net

3,651

3,891

Finance lease right of use assets

1,330

1,355

Operating lease right of use assets

2,539

2,610

Intangible assets, net

97,508

101,107

Goodwill

284,635

284,635

Other assets

 

3,736

 

3,472

Total assets

$

425,942

$

432,447

 

 

Liabilities and Shareholders’ Equity

 

 

Current liabilities:

Accounts payable and accrued expenses

$

5,556

$

6,366

Deferred revenue - current portion

 

23,345

 

22,304

Finance lease liability - current portion

580

581

Operating lease liability - current portion

1,133

1,316

Contingent consideration - current portion

729

743

Total current liabilities

 

31,343

 

31,310

Deferred revenue - less current portion

2,236

1,602

Warrant liability

7,078

3,040

Deferred tax liability

17,144

17,494

Contingent consideration - less current portion

43,630

42,530

Term loans, net

26,694

26,632

Finance lease liability - less current portion

5

147

Operating lease liability - less current portion

 

2,916

 

2,927

Total liabilities

 

131,046

 

125,682

 

 

Commitments and contingencies

 

 

Shareholders’ equity:

 

 

Common stock

 

6

 

6

Exchangeable shares

 

50,637

 

54,224

Additional paid in capital

 

393,082

 

380,881

Accumulated other comprehensive income

 

261

 

6

Treasury stock

(8,343)

(5,633)

Accumulated deficit

(140,747)

(122,719)

Total shareholders' equity

 

294,896

 

306,765

Total liabilities and shareholders’ equity

$

425,942

$

432,447

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

3

Table of Contents

GTY TECHNOLOGY HOLDINGS INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (UNAUDITED)

(Amounts in thousands, except per share amounts)

Three Months Ended

Three Months Ended

March 31, 

March 31, 

    

2021

2020

    

Revenues

$

13,259

$

11,276

Cost of revenues

 

4,742

 

4,527

Gross Profit

 

8,517

 

6,749

Operating expenses

Sales and marketing

3,762

4,854

General and administrative

5,193

7,449

Research and development

2,985

3,798

Amortization of intangible assets

3,599

3,673

Restructuring charges

3,466

Change in fair value of contingent consideration

1,114

29

Total operating expenses

16,653

23,269

Loss from operations

(8,136)

(16,520)

Other income (expense)

Interest expense, net

(859)

(236)

Loss from repurchase/issuance of shares

(5,333)

(2,056)

Change in fair value of warrant liability

(4,038)

(1,563)

Other income, net

168

499

Total other income (expense), net

(10,062)

(3,356)

Loss before income taxes

(18,198)

(19,876)

Benefit from income taxes

170

2,521

Net loss

(18,028)

(17,355)

Net loss per share, basic and diluted

$

(0.32)

$

(0.33)

Weighted average common shares outstanding, basic and diluted

55,828

52,575

Net loss

$

(18,028)

$

(17,355)

Other comprehensive gain:

Foreign currency translation gain

255

2,049

Total other comprehensive gain

255

2,049

Comprehensive loss

$

(17,773)

$

(15,306)

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

4

Table of Contents

GTY TECHNOLOGY HOLDINGS INC.

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY (UNAUDITED)

(Amounts in thousands, except share amounts)

Three Months Ended March 31, 2021

Accumulated

Additional

Other

Total

Common Stock

Exchangeable Shares

Paid in

Treasury

Accumulated

Comprehensive

Shareholders’

    

Shares

    

Amount

    

Shares

    

Amount

    

Capital

    

Stock

    

Deficit

    

Income

    

Equity

Balance - December 31, 2020

 

55,570,282

$

6

 

5,972,779

$

54,224

$

390,232

$

(5,633)

$

(129,030)

$

6

$

309,805

Adjustment for correction of an error - warrant liability

(9,351)

6,311

(3,040)

Balance - December 31, 2020, as adjusted

55,570,282

6

5,972,779

54,224

380,881

(5,633)

(122,719)

6

306,765

Net loss

 

 

 

 

 

 

 

(18,028)

 

 

(18,028)

Foreign currency translation gain

255

255

Share-based compensation

1,823

1,823

Issuance of common stock

935,633

6,790

6,790

Common stock repurchases

(525,060)

(2,710)

(2,710)

Common stock issued for exchangeable shares

358,658

(358,658)

(3,587)

3,587

Vested and issued restricted stock units

1,095,689

Stock option exercises

792

1

1

Balance - March 31, 2021

 

57,435,994

$

6

 

5,614,121

$

50,637

$

393,082

$

(8,343)

$

(140,747)

$

261

$

294,896

Three Months Ended March 31, 2020

Accumulated

Additional

Other

Total

Common Stock

Exchangeable Shares

Paid in

Treasury

Accumulated

Comprehensive

Shareholders’

    

Shares

    

Amount

    

Shares

    

Amount

    

Capital

    

Stock

    

Deficit

    

Income

    

Equity

Balance - December 31, 2019

 

52,303,862

$

5

5,568,096

$

45,681

$

340,625

$

(5,174)

(71,460)

$

370

$

310,047

Adjustment for correction of an error - warrant liability

(9,351)

4,180

(5,171)

Balance - December 31, 2019, as adjusted

52,303,862

5

5,568,096

45,681

331,274

(5,174)

(67,280)

370

304,876

Net loss

 

(17,355)

(17,355)

Foreign currency translation gain

2,049

2,049

Share-based compensation

3,295

3,295

Share redemption (incremental shares issued)

334,254

2,056

2,056

Shares issued for contingent consideration

550,388

10,000

10,000

Vested and issued restricted stock units

 

31,250

Stock option exercises

 

3,699

4

4

Exchangeable shares converted to common stock

246,097

(246,097)

(2,461)

2,461

Balance - March 31, 2020

 

52,919,162

$

5

 

5,872,387

$

53,220

$

339,090

$

(5,174)

$

(84,635)

$

2,419

$

304,925

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

5

Table of Contents

GTY TECHNOLOGY HOLDINGS INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

(Amounts in thousands)

Three Months Ended

Three Months Ended

March 31, 

March 31, 

    

2021

2020

Cash flows from operating activities:

 

  

  

Net loss

$

(18,028)

$

(17,355)

Adjustments to reconcile net loss to net cash used in operating activities:

 

 

Depreciation of property and equipment

 

253

 

54

Amortization of intangible assets

3,599

3,673

Amortization of right of use assets

279

431

Share-based compensation

1,823

3,295

Deferred income tax benefit

(170)

(2,521)

Loss on issuance/repurchase of shares

5,333

2,056

Change in fair value of warrant liability

4,038

1,563

Amortization of deferred debt issuance costs

172

66

Accrual of paid in kind interest

130

Gain on extinguishment of debt

(239)

Bad debt expense

5

69

Loss on disposal of fixed assets

24

Change in fair value of contingent consideration

1,114

29

Changes in operating assets and liabilities:

 

 

Accounts receivable

 

(789)

 

522

Prepaid expenses and other assets

 

(1,536)

 

(1,122)

Accounts payable and accrued liabilities

 

(813)

 

(546)

Deferred revenue and other liabilities

1,747

(42)

Operating lease liabilities

 

(348)

 

(441)

Net cash used in operating activities

 

(3,406)

 

(10,269)

 

  

 

  

Cash flows from investing activities:

 

  

 

  

Capital expenditures

(31)

(1,111)

Net cash used in investing activities

 

(31)

 

(1,111)

 

 

  

Cash flows from financing activities:

 

  

 

  

Proceeds from borrowings, net of issuance costs

 

 

11,476

Contingent consideration payments

(28)

(27)

Stock options exercises

1

4

Common stock repurchases

(8,043)

Proceeds from issuance of common stock, net of costs

6,790

Proceeds from disposal of fixed assets

6

Repayments of finance lease liabilities

 

(144)

 

(136)

Net cash provided by (used in) financing activities

 

(1,418)

 

11,317

 

  

 

  

Effect of foreign currency on cash

 

(9)

 

(195)

 

 

Net change in cash and cash equivalents

(4,864)

(258)

Cash and cash equivalents, beginning of period

 

22,800

 

8,374

Cash and cash equivalents, end of period

$

17,936

$

8,116

 

  

 

  

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

6

Table of Contents

GTY TECHNOLOGY HOLDINGS INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

SUPPLEMENTAL CASH FLOWS DISCLOSURE

(Amounts in thousands)

Three Months Ended

Three Months Ended

March 31, 

March 31, 

2021

2020

Supplemental disclosure of cash flow information:

 

  

 

  

Cash paid for interest

$

510

$

Cash paid for income taxes

$

$

Noncash Investing and Financing Activities:

Exchangeable shares issued for contingent consideration

$

$

10,000

Share redemption (incremental shares issued)

$

$

2,056

Purchases of property and equipment included in accounts payable

$

$

382

Exchangeable shares converted to common stock

$

3,587

$

2,461

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

7

Table of Contents

NOTES TO CONDENSED CONSOLIDATED STATEMENTS

(UNAUDITED)

(Amounts in tables in thousands, except share and per share amounts)

Note 1. Organization and Business Operations

GTY Technology Holdings Inc. and its subsidiaries (“GTY” or the “Company”) offers a cloud-based suite of solutions primarily for North American state and local governments. GTY’s cloud-based suite of solutions for state and local governments addresses functions in procurement, payments, grant management, budgeting and permitting.

The Company is headquartered in Las Vegas, Nevada and has other offices in the United States and Canada.  The following is a brief description of the Company’s primary subsidiaries and their businesses.

Bonfire, a Procurement Business

Bonfire Interactive Ltd. was incorporated on March 5, 2012 under the laws of the Province of Ontario and its wholly owned subsidiary, Bonfire Interactive US Ltd., was incorporated in the United States on January 8, 2018 (collectively, “Bonfire” or “Procurement”). Bonfire is a provider of strategic sourcing and procurement software, serving customers in government, the broader public sector, and various highly regulated commercial vertical markets. Bonfire offers customers and their sourcing professionals a modern software-as-a-service (“SaaS”) application that helps find, engage, evaluate, negotiate and award vendor and supplier contracts. Bonfire delivers workflow automation, data collection and analysis, and collaboration to drive cost savings, compliance, and strategic outcomes. All of Bonfire’s applications are delivered as a SaaS offering, and Bonfire offers implementation and premium support services.

CityBase, a Payments Business

CityBase, Inc. (“CityBase” or “Payments”), a Delaware corporation headquartered in Chicago, provides dynamic content, digital services, and integrated payments via a SaaS platform that includes technological functionality accessible via web and mobile, kiosk, point-of-sale, and other channels. CityBase software integrates its platform to underlying systems of record, billing, and other source systems, and configures payments and digital services to meet the requirements of its customers, which include government agencies and utility companies.

eCivis, a Grants Management Business

eCivis, Inc. (“eCivis” or “Grants Management”), a Delaware corporation headquartered in Los Angeles, California, is a leading SaaS provider of grants management and indirect cost reimbursement solutions that enable its customers to standardize and streamline complex grant processes in a fully integrated platform. The eCivis platform consists of four core cloud-based products, including grants research, grants management, sub-recipient management, and cost allocation and recovery. To assist its customers in the implementation of its cloud-based products, eCivis offers one-time implementation services, including data integration, grants migration and change management. Additionally, eCivis provides ongoing grants management training, cost allocation plan consulting and cost recovery services.

Open Counter, a Permitting Business

Open Counter Enterprises Inc. (“Open Counter” or “Permitting”), a Delaware corporation headquartered in Boston, Massachusetts, is a developer and provider of software tools for cities to streamline permitting and licensing services for municipal governments. Open Counter provides customers with software through a hosted platform and provides professional services related to software implementation.

Questica, a Budget Business

Questica Software Inc., Questica USCDN Inc. and its wholly-owned subsidiary Questica Ltd. (collectively, “Questica”) design and develop budgeting software that supports the unique requirements of the public sector. The Questica suite of products are part of a comprehensive web-based budgeting preparation, performance, management and data visualization solution that enables public sector and non-profit organizations to improve and shorten their budgeting cycles.

8

Table of Contents

NOTES TO CONDENSED CONSOLIDATED STATEMENTS

(UNAUDITED)

(Amounts in tables in thousands, except share and per share amounts)

Questica Software Inc. was organized in 1998 as an Ontario corporation, maintains two offices located in Burlington, Ontario, Canada and serves the healthcare, K-12, higher education and local government verticals primarily in North America. Questica USCDN was organized in 2017 as an Ontario corporation and Questica Ltd. was incorporated in 2017 in the United States as a Delaware corporation. Questica Ltd. is located in Huntington Beach, California, primarily serving the non-profit market and services a limited number of customers in the public and private sector. The majority of Questica Ltd.’s customers are located in the United States and Canada, with some customers located in the United Kingdom and Africa, among other countries.

Sherpa, a Budget Business

Sherpa Government Solutions LLC (“Sherpa” and, collectively with Questica, “Budget”) is a Colorado limited liability company headquartered in Denver, Colorado, established in 2004. Sherpa is a leading provider of public sector budgeting software and consulting services that help state and local governments create and manage budgets and performance. Customers purchase Sherpa’s software and then engage its consulting services to configure the software and receive training on how to manage the software going forward.  Following implementation, customers continue to use the software in exchange for maintenance or subscription fees.

Note 2. Restatement of Previously Issued Financial Statements

On April 12, 2021, the Acting Director of the Division of Corporation Finance and Acting Chief Accountant of the Securities and Exchange Commission together issued a “Staff Statement on Accounting and Reporting Considerations for Warrants Issued by Special Purpose Acquisition Companies (“SPACs”)” (the “SEC Statement”), concluding that SPAC warrants may require classification as a liability rather than equity. The SEC Statement discussed “certain features of warrants issued in SPAC transactions” that “may be common across all entities”. It focused in part on provisions in warrant agreements for potential changes to the settlement amounts dependent upon the characteristics of the warrant holder, and specifically whether the warrant holder is an input into the pricing of a fixed-for-fixed option on equity shares. According to the SEC Staff Statement, if the warrant holder is not an input into such pricing, these provisions would preclude the warrant from being classified in equity and thus require classification as a liability. As a result of the SEC Statement, the Company reevaluated the accounting treatment of the public warrants and private warrants issued in connection with its initial public offering and previously recorded as equity on the Company’s consolidated balance sheet. The Company’s public warrants were correctly classified as equity. Because the Company’s private warrants do not contain a provision whereby the Company can call the warrants, however, the private warrants should have been recorded at fair value as a liability in the Company’s consolidated balance sheet. The Company assessed this error and determined it was not material to previously issued financial statements. Accordingly, the Company will revise, rather than restate, its previously issued 2020 quarterly and annual financial statements in the Company’s filings for 2021 on Forms 10-Q and 10-K filings.  Additionally, the historical quarterly and annual financial statements prior to the business combination were not restated due to the change in accounting as we believe the information is no longer relevant to investors.  

The following tables present the effect of the revision for the financial statement line items adjusted in the affected periods:

Condensed Consolidated Statements of Operations and Comprehensive Loss

Quarter Ended March 31, 2020

As Previously Reported

Adjustments

As Revised

Change in fair value of warrant liability

$

$

1,563

$

1,563

Net loss

$

15,792

$

1,563

$

17,355

Comprehensive loss

$

13,743

$

1,563

$

15,306

Net loss per share, basic and diluted

$

(0.30)

$

(0.03)

$

(0.33)

9

Table of Contents

NOTES TO CONDENSED CONSOLIDATED STATEMENTS

(UNAUDITED)

(Amounts in tables in thousands, except share and per share amounts)

Condensed Consolidated Statements of Cash Flows

Quarter Ended March 31, 2020

As Previously Reported

Adjustments

As Revised

Net loss

$

15,792

$

1,563

$

17,355

Change in fair value of warrant liability

$

$

1,563

$

1,563

Condensed Consolidated Balance Sheet

As of December 31, 2020

As Previously Reported

Adjustments

As Revised

Warrant liability

$

$

3,040

$

3,040

Additional paid in capital

$

390,232

$

(9,351)

$

380,881

Accumulated deficit

$

(129,030)

$

6,311

$

(122,719)

Note 3. Summary of Significant Accounting Policies

Basis of Presentation

The accompanying condensed consolidated financial statements were prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information. Certain information and disclosures normally included in condensed consolidated financial statements prepared in accordance with GAAP have been condensed or omitted. The accompanying condensed consolidated financial statements should be read in conjunction with the Company's audited financial statements and notes thereto included in the Company's Annual Report on Form 10-K for the year ended December 31, 2020 filed with the Securities and Exchange Commission (“SEC”) on February 19, 2021. Certain reclassifications have been made to conform to current period presentation.

Principles of Consolidation

The three months ended March 31, 2021 and 2020 condensed consolidated financial statements include all accounts of the Company and its subsidiaries. All material intercompany transactions and balances have been eliminated in the accompanying condensed consolidated financial statements.

Use of Estimates

The preparation of the condensed consolidated financial statements and related disclosures in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the balance sheets and the reported amounts of revenues and expenses during the reporting periods. Significant items subject to such estimates include revenue recognition, the carrying value of goodwill, the fair value of acquired intangibles, the capitalization of software development costs, the useful lives of intangible assets, share-based compensation, right of use assets, warrant liability, financing and operating lease liabilities, contingent consideration and the valuation allowance of deferred tax assets resulting from net operating losses.

Covid-19 Update

In December 2019, the emergence of a novel coronavirus, or COVID-19, was reported and in March 2020, the World Health Organization, or WHO, characterized COVID-19 as a pandemic.  The broader implications of the global emergence of COVID-19 on the Company’s business, operating results, and overall financial performance remain uncertain and they depend on certain developments, including the duration and spread of the outbreak, impact on the Company’s

10

Table of Contents

NOTES TO CONDENSED CONSOLIDATED STATEMENTS

(UNAUDITED)

(Amounts in tables in thousands, except share and per share amounts)

customers and its sales cycles, impact on its partners or employees, and impact on the economic environment and financial markets, all of which are uncertain and cannot be predicted.  Since March 2020, the Company has seen certain new and existing customers halt or decrease investment in infrastructure, and the Company expects that certain of its current and potential customers will take actions to reduce operating expenses and moderate cash flows, including by delaying sales and requesting extended billing and payment terms. The Company will continue to actively monitor the situation and may take further actions that alter its business operations, as may be required by federal, state, or local authorities, or that the Company determines are in the best interests of its employees, customers, partners, suppliers, and stockholders.

Significant Accounting Policies

 

There have been no material changes to the Company’s significant accounting policies previously disclosed in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2020 as filed with the SEC on February 19, 2021 aside from those described in Note 2.

Fair Value

The fair value of an asset or liability is the price that would be received to sell an asset or transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The Company utilizes a fair value hierarchy that maximizes the use of observable inputs and minimizes the use of unobservable inputs when measuring fair value and defines three levels of inputs that may be used to measure fair value.

Level 1 — uses quoted prices in active markets for identical assets or liabilities.
Level 2 — uses observable inputs other than quoted prices in Level 1, such as quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets and liabilities in markets that are not active; or other inputs that are observable or can be corroborated by observable market data.
Level 3 — uses one or more significant inputs that are unobservable and supported by little or no market activity, and that reflect the use of significant management judgment.

The Company’s only material financial instruments carried at fair value as of March 31, 2021 and December 31, 2020, with changes in fair value flowing through current earnings, consist of contingent consideration liabilities recorded in conjunction with business combinations and the fair value of its warrant liabilities are as follows:

Fair Value Measurement at

Reporting Date Using

    

    

Quoted Prices in

    

Significant

    

Active Markets

Other

Significant

Balance as of

for Identical

Observable

Unobservable

March 31, 

Assets

Inputs

Inputs

2021

(Level 1)

(Level 2) 

(Level 3)

Contingent consideration – current

$

729

$

$

$

729

Contingent consideration – long term

 

43,630

 

 

 

43,630

Warrant liability

7,078

7,078

Total liabilities measured at fair value

$

51,437

$

$

$

51,437

11

Table of Contents

NOTES TO CONDENSED CONSOLIDATED STATEMENTS

(UNAUDITED)

(Amounts in tables in thousands, except share and per share amounts)

Fair Value Measurement at

Reporting Date Using

    

    

Quoted Prices in

    

Significant

    

Active Markets

Other

Significant

Balance as of

for Identical

Observable

Unobservable

December 31, 

Assets

Inputs

Inputs

2020

(Level 1)

(Level 2) 

(Level 3)

Contingent consideration – current

$

743

$

$

$

743

Contingent consideration – long term

 

42,530

 

 

 

42,530

Warrant liability

3,040

3,040

Total liabilities measured at fair value

$

46,313

$

$

$

46,313

There were no transfers made among the three levels in the fair value hierarchy during the three months ended March 31, 2021.

The following tables present additional information about Level 3 liabilities measured at fair value. Both observable and unobservable inputs may be used to determine the fair value of positions that the Company has classified within the Level 3 category. As a result, the unrealized gains and losses for liabilities within the Level 3 category may include changes in fair value that were attributable to both observable (e.g., changes in market interest rates) and unobservable (e.g., changes in unobservable long-dated volatilities) inputs.

Changes in contingent consideration liabilities measured at fair value from December 31, 2020 to March 31, 2021 were as follows:

Contingent consideration – December 31, 2020

    

$

43,273

Change in fair value of contingent consideration

 

1,114

Payments of contingent consideration

(28)

Contingent consideration – March 31, 2021

$

44,359

On February 19, 2019, the Company consummated several acquisitions (collectively, the “Acquisition”), pursuant to which it acquired each of Bonfire, CityBase, eCivis , Open Counter, Questica and Sherpa (together with Bonfire, CityBase, eCivis, Open Counter and Questica, the “Acquired Companies”).

The fair value of the Company’s contingent consideration liabilities recorded as part of the Acquisition has been classified within Level 3 in the fair value hierarchy. The contingent consideration represents the estimated fair value of future payments due to the sellers based on each company’s achievement of annual earnings targets in certain years and other events considered in certain transaction documents. The initial fair values of the contingent consideration were calculated through the use of either Monte Carlo simulation or modified Black-Scholes analyses based on earnings projections for the respective earn-out periods, corresponding earnings thresholds, and approximate timing of payments as outlined in the purchase agreements for each of the Acquired Companies. The analyses utilized the following assumptions: (i) expected term; (ii) risk-adjusted net sales or earnings; (iii) risk-free interest rate; and (iv) expected volatility of earnings. Estimated payments, as determined through the respective models, were further discounted by a credit spread assumption to account for credit risk. The contingent consideration is revalued to fair value each period, and any increase or decrease is recorded in operating income (loss). The fair value of the contingent consideration may be impacted by certain unobservable inputs, most significantly with regard to discount rates, expected volatility and historical and projected performance. Significant changes to these inputs in isolation could result in a significantly different fair value measurement.

Changes in the warrant liability measured at fair value from December 31, 2020 to March 31, 2021 were as follows:

12

Table of Contents

NOTES TO CONDENSED CONSOLIDATED STATEMENTS

(UNAUDITED)

(Amounts in tables in thousands, except share and per share amounts)

Warrant liability – December 31, 2020

$

3,040

Change in fair value of warrant liability

 

4,038

Warrant liability – March 31, 2021

$

7,078

The warrant liability was estimated using a Black-Scholes model derived from a Monte Carlo simulation of the Company’s outstanding public warrants.  These inputs were primarily derived from the implied volatility of the traded public warrant price.

The carrying value of cash and cash equivalents, accounts receivable, accounts payable and accrued liabilities, and term loans approximates fair value because of the short-term nature of these instruments.

The Company measures certain assets at fair value on a non-recurring basis, generally annually or when events or changes in circumstances indicate that the carrying amount of the assets may not be recoverable. These assets include goodwill and other intangible assets.

A financial instrument’s categorization within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement.

Disaggregation of Revenues

Three Months Ended

Three Months Ended

March 31, 

March 31, 

    

2021

  

2020

Subscriptions, support and maintenance

$

10,165

  

$

7,724

Professional services

 

2,941

  

 

3,169

License

 

63

  

 

383

Asset sales

 

90

  

 

Total revenues

$

13,259

  

$

11,276

Revenues

Subscription, support and maintenance. The Company provides SaaS that provide customers with access to SaaS related support and updates during the term of the arrangement. Revenues are recognized ratably over the contract term as the customer simultaneously receives and consumes the benefits of the subscription service, as the service is made available by the Company. The first year of subscription fees are typically payable within 30 days after the execution of a contract, and thereafter upon renewal. The Company initially records subscription fees as contract liabilities and recognizes revenues on a straight-line basis over the term of the agreement.

The Company’s contracts may include variable consideration in the form of usage fees, which are constrained and recognized once the uncertainties associated with the constraint are resolved, which is when usage occurs and the fee is known.

Subscription, support and maintenance revenues also includes on-premise support or maintenance pertaining to license sales. Revenues from on-premise support are recognized on a straight-line basis over the support period.

Revenues from subscription, support and maintenance comprised approximately 77% and 68% of total revenues for the three months ended March 31, 2021 and 2020, respectively.

13

Table of Contents

NOTES TO CONDENSED CONSOLIDATED STATEMENTS

(UNAUDITED)

(Amounts in tables in thousands, except share and per share amounts)

Professional services.    The Company’s professional services contracts generate revenues on a time and materials or fixed fee basis. Revenues are recognized as the services are rendered for time and materials contracts. Revenues are recognized when the milestones are achieved and accepted by the customer or on a proportional performance basis for fixed fee contracts. Training revenues are recognized as the services are performed. Revenues from professional services comprised approximately 22% and 28% of total revenues for the three months ended March 31, 2021 and 2020, respectively.

License. Revenues from distinct licensed software are recognized upfront when the software is made available to the customer, which normally coincides with contract execution, as this is when the customer has the risks and rewards of the right to use the software. Revenues from licenses comprised approximately less than 1% and 3% of total revenues for the three months ended March 31, 2021 and 2020, respectively.

Asset sales. Revenues from asset sales are recognized when the asset, typically a kiosk, has been received by the customer and is fully operational and ready to accept transactions, which is when the customer obtains control and has the risks and rewards of the asset. Asset sales were approximately 1% and less than 1% of total revenues for the three months ended March 31, 2021 and 2020, respectively.

Restructuring Charges

On March 30, 2020, the Company implemented a global restructuring plan which resulted in an approximate 10% reduction of the Company’s workforce.  This action was intended to streamline the Company’s operational reporting and reduce operating cash outflows.  The Company recorded pre-tax restructuring charges of approximately $3.5 million which is comprised of one-time employee termination benefits paid over a weighted-average period of approximately 10 months.  All termination benefits associated with the restructuring plan have been paid as of March 31, 2021.  

Net Loss per Share

Net loss per share of common stock is computed by dividing net loss by the weighted-average number of shares of common stock outstanding during the period. Diluted net income per share of common stock is computed similarly to basic net income per share of common stock except that it reflects the potential dilution that could occur if dilutive securities or other obligations to issue common stock were exercised or converted into common stock. Due to the net loss for the three months ended March 31, 2021 and 2020, diluted and basic loss per share are the same.

Securities that could potentially dilute net loss per share in the future that were not included in the computation of diluted loss per share at March 31, 2021 and 2020 are as follows:

2021

2020

Warrants to purchase common stock

    

27,093,334

27,093,334

Unvested restricted stock units

 

3,173,584

4,022,110

Options to purchase common stock

 

245,112

261,027

Total

 

30,512,030

31,376,471

Income Taxes

In determining the quarterly benefit from income taxes, the Company uses the annual estimated effective tax rate applied to the actual year-to-date loss, adjusted for discrete items arising in that quarter.  The Company’s annual estimated effective tax rate differs from the U.S. federal statutory rate of 21% as a result of state taxes, foreign taxes and changes in the

14

Table of Contents

NOTES TO CONDENSED CONSOLIDATED STATEMENTS

(UNAUDITED)

(Amounts in tables in thousands, except share and per share amounts)

Company’s valuation allowance for domestic income taxes.  For the three months ended March 31, 2021 and 2020, the Company recorded a $0.2 million and $2.5 million benefit from income taxes, respectively.  

Recently Adopted Accounting Pronouncements

On January 1, 2020, the Company adopted Accounting Standards Update (“ASU”) No. 2018-13, Changes to Disclosure Requirements for Fair Value Measurements (Topic 820), which improved the effectiveness of disclosure requirements for recurring and nonrecurring fair value measurements.  The standard removes, modifies, and adds certain disclosure requirements.  The adoption of this new standard did not have a material impact on the Company’s condensed consolidated financial statements.

On January 1, 2020, the Company adopted ASU No. 2018-15, Intangibles-Goodwill and Other-Internal-Use Software (Subtopic 350-40) – Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract.  ASU 2018-15 aligns the accounting for implementation costs incurred in a hosting arrangement that is a service contract with the accounting for implementation costs incurred to develop or obtain internal-use software under Accounting Standards Codification (“ASC”) 350-40 – Internal Use Software, in order to determine which costs to capitalize and recognize as an asset and which costs to expense.  The adoption of this new standard did not have a material impact on the Company’s condensed consolidated financial statements.

On January 1, 2021, the Company adopted ASU 2019-12, Income Taxes (Topic 740), Simplifying the Accounting for Income Taxes.   ASU 2019-12 simplifies various aspects related to accounting for income taxes, removes certain exceptions to the general principles in Topic 740 and clarifies and amends existing guidance to improve consistent application. The adoption of this new standard did not have a material impact on the Company’s condensed consolidated financial statements.

Recently Issued Accounting Pronouncements

In August 2020, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update No. 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity's Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity's Own Equity (ASU 2020-06), which simplifies the accounting for convertible instruments by reducing the number of accounting models available for convertible debt instruments. This guidance also eliminates the treasury stock method to calculate diluted earnings per share for convertible instruments and requires the use of the if-converted method. This guidance will be effective for the Company in the first quarter of 2022 on a full or modified retrospective basis, with early adoption permitted. The Company does not expect the adoption of this guidance to have a material impact on its consolidated financial statements.

15

Table of Contents

NOTES TO CONDENSED CONSOLIDATED STATEMENTS

(UNAUDITED)

(Amounts in tables in thousands, except share and per share amounts)

Note 4. Intangible Assets

The Company recognized goodwill and certain identifiable intangible assets in connection with business combinations. Identifiable intangible assets consist of the following as of March 31, 2021 and March 31, 2020:

March 31, 2021

Gross Carrying Amount

Accumulated Amortization

Net Carrying Amount

Patents / Developed Technology

$

60,084

$

(15,878)

$

44,206

Trade Names / Trademarks

16,348

(3,623)

12,725

Customer Relationships

51,003

(10,770)

40,233

Non-Compete Agreements

1,162

(818)

344

Total Intangibles

$

128,597

$

(31,089)

$

97,508

December 31, 2020

Gross Carrying Amount

Accumulated Amortization

Net Carrying Amount

Patents / Developed Technology

$

60,084

$

(14,026)

$

46,058

Trade Names / Trademarks

16,348

(3,227)

13,121

Customer Relationships

51,003

(9,514)

41,489

Non-Compete Agreements

1,162

(723)

439

Total Intangibles

$

128,597

$

(27,490)

$

101,107

Amortization expense recognized by the Company related to intangible assets for the three months ended March 31, 2021 and March 31, 2020 was $3.6 million and $3.7 million, respectively.

The estimated aggregate future amortization expense for intangible assets is as follows:

Nine months ended December 31, 2021

 

11,012

Year ended December 31, 2022

 

14,276

Year ended December 31, 2023

 

14,224

Year ended December 31, 2024

 

14,263

Year ended December 31, 2025

14,224

Thereafter

 

29,509

$

97,508

Note 5. Leases

The Company leases office space under agreements classified as operating leases that expire on various dates through 2030. Such leases do not require any contingent rental payments, impose any financial restrictions, or contain any residual value guarantees. Certain of the Company’s leases include renewal options and escalation clauses; renewal options have not been included in the calculation of the lease liabilities and right of use assets as the Company is not reasonably certain to exercise the options. Variable expenses generally represent the Company’s share of the landlord’s operating expenses.

At March 31, 2021, the Company had operating right of use assets of approximately $2.5 million and operating lease liabilities of approximately $4.0 million, which are included in the condensed consolidated balance sheet.

The Company purchases kiosks that are funded by finance leases that expire on various dates through 2023 and are included in fixed assets.  At March 31, 2021, the Company had finance lease right of use assets of $1.3 million and finance lease liabilities of approximately $0.6 million.  

16

Table of Contents

NOTES TO CONDENSED CONSOLIDATED STATEMENTS

(UNAUDITED)

(Amounts in tables in thousands, except share and per share amounts)

The following summarizes quantitative information about the Company’s leases:

Three Months Ended March 31, 2021:

    

Grants

Procurement

    

Payments

    

Management

Budget

    

Total

Finance lease cost

Amortization of right-of-use assets

$

$

15

$

$

$

15

Interest

26

26

Operating lease cost

114

115

20

109

358

Total lease cost

$

114

$

156

$

20

$

109

$

399

    

Grants

 

Procurement

    

Payments

    

Management

Budget

    

Total

Weighted-average remaining lease term – finance leases

N/A

1.0

N/A

N/A

1.0

Weighted-average remaining lease term – operating leases

 

1.2

 

0.7

1.8

 

9.5

 

7.2

Weighted-average discount rate – finance leases

N/A

13.0

%  

N/A

N/A

13.0

%

Weighted-average discount rate – operating leases

 

9.9

%  

 

10.0

%  

8.0

%  

 

4.8

%  

 

6.2

%

As of March 31, 2021, future minimum lease payments under non-cancellable leases are as follows:

    

Grants

Operating

Finance

Procurement

    

Payments

    

Management

Budget

    

Leases

 

Leases

Nine months ended December 31, 2021

$

365

$

343

$

90

$

318

$

1,026

$

439

Year Ended December 31, 2022

 

247

123

 

430

 

677

197

Year Ended December 31, 2023

 

10

 

383

 

383

Year Ended December 31, 2024

 

 

368

 

368

Year Ended December 31, 2025

417

417

Thereafter

 

 

2,109

 

2,109

Total

$

612

$

343

$

223

$

4,025

$

4,980

$

636

Less present value discount

 

(27)

(21)

(16)

(883)

(931)

(51)

Present value of lease liabilities

$

585

$

322

$

207

$

3,142

$

4,049

$

585

Note 6. Term Loans

Credit Facility

On February 14, 2020, the Company entered into an unsecured term loan credit facility (“February 2020 Credit Facility”) that provided for borrowing of term loans in an aggregate principal amount of $12.0 million.  The credit facility had a maturity date of twelve months from the borrowing date of the term loans.  On the closing date, the Company fully drew on the credit facility net of deferred issuance costs of $0.7 million.  The $0.7 million of deferred issuance costs included $0.4 million of fees to be applied against interest and $0.3 million of other issuance costs.  Amounts outstanding under the credit facility bore interest from the date the term loans were first made until the last day of the fiscal month immediately following the six-month anniversary of such initial borrowing date at a rate per annum equal to twelve percent.  Commencing on the first day of each fiscal month thereafter, the interest rate increased by one percent per annum until the termination date.  The February 2020 Credit Facility was terminated on November 13, 2020 and $0.2 million of unamortized deferred issuance costs were expensed and included in other income, net.

17

Table of Contents

NOTES TO CONDENSED CONSOLIDATED STATEMENTS

(UNAUDITED)

(Amounts in tables in thousands, except share and per share amounts)

On November 13, 2020, the Company entered into a senior secured term loan facility (“November 2020 Credit Facility”) that provides for borrowing of term loans in an aggregate principal amount of $25,000,000. The November 2020 Credit Facility has a maturity date of 30 months from the borrowing of the term loans. On the closing date, the Company fully drew on the November 2020 Credit Facility and replaced the February 2020 Credit Facility. Amounts outstanding under the November 2020 Credit Facility accrue interest at a rate of eight percent plus LIBOR or 8.15% at March 31, 2021 and two percent payment-in-kind (“PIK”) interest.  The November 2020 Credit Facility is supported by a security interest in the assets of the Company and includes certain financial covenants pertaining to annual recurring revenue, revenue, and cash.  As of March 31, 2021, the Company was compliant with all financial covenants.

For the three months ended March 31, 2021 and 2020, the Company recognized $0.7 million and $0.2 million of interest expense, respectively, under the February 2020 and November 2020 Credit Facilities and approximately $0.2 million and $0.1 million of debt issuance costs, respectively.  At March 31, 2021, the Company had accrued approximately $0.2 million of accrued interest.

Paycheck Protection Plan Loans (PPP Loans)

In April and May 2020, the Company’s subsidiaries CityBase, eCivis, and Sherpa received $2.0 million, $0.9 million and $0.2 million, respectively, in loan proceeds from the Paycheck Protection Program (the “PPP”) administered by the Small Business Administration of the United States government.  This program was established under the Coronavirus Aid, Relief and Economic Security Act (the “CARES Act”), which was created to provide fast and direct economic assistance for American workers, families, small businesses, and preserves jobs for American industries.  The Company used the funds to support the compensation expenses related to its U.S. employees.  These loans mature two years from the date of issuance and accrue interest at a rate of one percent per annum.  As of March 31, 2021 and December 31, 2020, the Company accounted for these loans in accordance with ASC 470.  The Company obtained forgiveness for the $0.2 million in loan proceeds pertaining to the loan received by Sherpa and expects to seek forgiveness for the remaining loans during the year ended December 31, 2021.

The Company’s term loans are summarized as follows:

November 2020
Credit Facility

PPP Loans

Total

Principal

$ 25,000

$ 2,971

$ 27,971

Payment-in-kind ("PIK") accrued interest

199

199

Unamortized deferred issuance costs

(1,476)

(1,476)

Term loans, net

$ 23,723

$ 2,971

$ 26,694

Maturity Date

May 2023

April and May 2022

Interest Rate

8% + LIBOR

1%

PIK Interest Rate

2%

0%

Note 7. Commitments and Contingencies

Legal Proceedings

From time to time, the Company may become involved in legal proceedings arising in the ordinary course of its business. The Company is not currently a party to any legal proceedings that, if determined adversely to the Company, would have a material adverse effect on the Company.

18

Table of Contents

NOTES TO CONDENSED CONSOLIDATED STATEMENTS

(UNAUDITED)

(Amounts in tables in thousands, except share and per share amounts)

Indemnification

Additionally, in the ordinary course of business, the Company may provide indemnification of varying scope and terms to customers, vendors, investors, directors and officers with respect to certain matters, including, but not limited to, losses arising out of our breach of such agreements, services to be provided by the Company, or from intellectual property infringement claims made by third parties. These indemnification provisions may survive termination of the underlying agreement and the maximum potential amount of future payments that the Company could be required to make under these indemnification provisions may not be subject to maximum loss clauses. The maximum potential amount of future payments that the Company could be required to make under these indemnification provisions is indeterminable. The Company has never paid a material claim, nor has it been sued in connection with these indemnification arrangements.

As of March 31, 2021 and December 31, 2020, the Company has not accrued a liability for any legal proceedings, claims or indemnification arrangements because the likelihood of incurring a payment obligation, if any, in connection with them is not probable or reasonably estimable.

Note 8. Shareholders’ Equity

Common Stock – GTY is authorized to issue 400,000,000 shares of common stock with a par value of $0.0001 per share.

On November 25, 2020, the Company entered into an At Market Sales Agreement with B. Riley Securities, Inc. (“B. Riley”) and Needham & Company (“Needham” and together with B. Riley, the “Sales Agents”) with respect to an at-the-market offering program under which the Company may offer and sell, from time to time at its sole discretion, shares of its common stock, par value $0.0001 per share, having an aggregate offering price of up to $10.0 million through B. Riley and Needham as its sales agents. The issuance and sale, if any, of shares of common stock by the Company under the At Market Sales Agreement will be made pursuant to the Company’s effective registration statement on Form S-3.  During the three months ended March 31, 2021, the Company sold 935,633 of common shares for $6.8 million in proceeds.

During the three months ended March 31, 2021, the Company issued 358,658 of common shares for the same number of exchangeable shares to the former shareholders of Questica and Bonfire.

Share Redemptions

Under the agreements with eCivis, the Company acquired eCivis for aggregate consideration of approximately $14.0 million in cash and 2,883,433 shares of Company common stock, including 703,631 shares of the Company’s common stock which are redeemable for cash at any time in the sole discretion of the Company for a price of $10.00 per share (the “Redeemable Shares”).  Upon redemption of the Redeemable Shares, the Company must simultaneously redeem additional shares from the holder equal to 40% of the number of Redeemable Shares being redeemed (the “Additional Shares”) at $10 per share.  If the Redeemable Shares were not redeemed by February 12, 2020 and February 12, 2021, the Company was required to issue additional shares, as calculated based on the number of outstanding Redeemable Shares. In June 2019, 178,571 Redeemable Shares and 71,428 Additional Shares were redeemed and the Company recorded a $0.8 million loss.  During February 2020, the Company issued 334,254 Additional Shares and recorded a $2.1 million loss.  The remaining 525,060 shares of common stock were redeemed for a total of $8.0 million and the Company recorded a $5.3 million loss during the three months ended March 31, 2021.

Preferred Shares – GTY is authorized to issue 25,000,000 preferred shares with a par value of $0.0001 per share. As of March 31, 2021 and December 31, 2020, there were no preferred shares issued or outstanding.

19

Table of Contents

NOTES TO CONDENSED CONSOLIDATED STATEMENTS

(UNAUDITED)

(Amounts in tables in thousands, except share and per share amounts)

Warrants

At March 31, 2021 and December 31, 2020, there were a total of 27,093,334 warrants outstanding including 18,400,000 public warrants and 8,693,334 private warrants. The warrants were originally sold as part of the units offered in the Company’s initial public offering and expire five years from the date of the acquisition or February 2024. Each warrant entitles the holder thereof to purchase one share of common stock at a price of $11.50 per share, subject to adjustments. The warrants may be exercised only for a whole number of shares of common stock. No fractional shares will be issued upon exercise of the warrants.

The Company may call the public warrants for redemption, in whole and not in part, at a price of $0.01 per warrant, upon not less than 30 days’ prior written notice of redemption to each warrant holder, if, and only if, the reported last sale price of common stock equals or exceeds $18.00 per share for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date the Company sends the notice of redemption to the warrant holders. The private warrants are not callable for redemption and are marked to market and included in warrant liabilities with non-cash fair value adjustments recorded into earnings during each reporting period.

Note 9. Share-Based Compensation

Stock Options

In connection with the Acquisition, the Company adopted a stock option plan and issued 408,667 stock options to employees. The total fair value of the stock options at the grant date was $3.6 million.

A summary of stock option activity is as follows:

    

    

    

Weighted

    

Average

Weighted

Remaining

Average

Contractual

Total

Number of

Exercise

Life (in

Intrinsic

Shares

Price

years)

Value

Outstanding as of December 31, 2020

 

245,904

$

2.26

 

7.0

$

1,130

Granted

 

 

 

 

Exercised

 

(792)

1.16

Forfeited/expired

 

Outstanding as of March 31, 2021

 

245,112

$

2.26

 

6.7

$

1,126

Options vested and exercisable

 

191,248

$

2.25

6.6

$

880

For the three months ended March 31, 2021 and 2020, the Company recorded approximately $0.1 million of share-based compensation expense related to the options. As of March 31, 2021, the Company has $0.4 million of unrecognized share-based compensation cost to be recognized over 0.5 years.

Restricted Stock Units

Subsequent to the Acquisition, the Company adopted a plan to issue restricted stock units (“RSUs”) to employees as annual performance awards.  RSUs may vest in ratable annual installments over either two or four years, as applicable, from the date, or RSUs may vest subject to the achievement of certain performance conditions over a three-year performance period, in each case, assuming continuous service by the employees through the applicable vesting dates.

A summary of the Company's RSU’s and related information is as follows:

20

Table of Contents

NOTES TO CONDENSED CONSOLIDATED STATEMENTS

(UNAUDITED)

(Amounts in tables in thousands, except share and per share amounts)

    

    

Weighted Average

Number of Units

Grant Price

Unvested as of December 31, 2020

 

3,280,290

$

4.94

Granted

 

816,162

6.92

Vested

(882,990)

4.70

Forfeited/expired

 

(39,878)

4.45

Unvested as of March 31, 2021

 

3,173,584

$

5.52

For the three months ended March 31, 2021 and 2020, the Company recorded approximately $1.7 million and $3.2 million, respectively, of share-based compensation expense related to the RSUs. As of March 31, 2021, the Company had unrecognized share-based compensation expense related to all unvested RSUs of $14.5 million. The weighted average remaining contractual term of unvested RSUs is approximately 1.3 years at March 31, 2021.  825,590 of the unvested RSUs contain performance conditions subject to achieving segment specific revenue and profitability metrics.  

Note 10. Segment Reporting

The Company conducts its business through the following five operating segments: Procurement, Payments, Grants Management, Permitting, and Budget.

The accounting policies of the operating segments are the same as those described in Note 3. The following provides operating information about the Company’s reportable segments for the periods presented:

    

Corporate

    

Procurement

    

Payments

    

Grants Management

    

Permitting

    

Budget

    

Total

Three Months Ended March 31, 2021

 

  

 

  

 

  

 

  

 

  

 

  

 

  

Total revenue

$

2,437

2,229

1,750

695

6,148

$

13,259

Cost of revenues

 

470

1,566

650

154

1,902

 

4,742

Income (loss) from operations

 

(1,756)

(805)

(4,846)

(969)

(387)

627

 

(8,136)

Amortization of intangible assets

651

1,355

323

297

973

3,599

Depreciation expense

47

94

9

2

101

253

Interest income (expense), net

(844)

(12)

(3)

(859)

Benefit from (provision for) income taxes

170

170

Three Months Ended March 31, 2020

 

  

Total revenue

$

1,656

1,899

1,465

613

5,643

$

11,276

Cost of revenues

 

392

1,470

722

139

1,804

 

4,527

Income (loss) from operations

 

(5,520)

(2,114)

(6,352)

(1,449)

(886)

(199)

 

(16,520)

Amortization of intangible assets

667

1,365

323

300

1,018

3,673

Depreciation expense

16

18

8

1

11

54

Interest income (expense), net

(205)

(1)

(30)

(236)

Benefit from (provision for) income taxes

113

1,785

428

247

(52)

2,521

As of March 31, 2021

 

 

  

Goodwill

$

68,744

88,327

45,140

21,956

60,468

$

284,635

Assets

 

26,630

92,306

109,142

54,976

27,526

115,362

 

425,942

As of December 31, 2020

 

 

  

Goodwill

$

68,744

88,327

45,140

21,956

60,468

$

284,635

Assets

 

31,407

92,841

110,339

55,676

28,474

113,710

 

432,447

Revenues from North America customers accounted for greater than 90% of the Company’s revenues for the periods presented.

21

Table of Contents

NOTES TO CONDENSED CONSOLIDATED STATEMENTS

(UNAUDITED)

(Amounts in tables in thousands, except share and per share amounts)

Note 11. Subsequent Events

The Company has evaluated events from March 31, 2021 through the date the financial statements were issued. There were no subsequent events that need disclosure.

22

Table of Contents

Item 2.   Management’s Discussion and Analysis of Financial Condition and Results of Operations

You should read the following discussion and analysis of our financial condition and results of operations together with the financial statements and related notes that are included elsewhere in this Quarterly Report on Form 10-Q and in our Annual Report on Form 10-K filed with the SEC on February 19, 2021. Certain statements in this Quarterly Report on Form 10-Q are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). These statements involve a number of risks, uncertainties and other factors that could cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by these forward-looking statements. Factors that could materially affect such forward-looking statements can be found in the section entitled “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2020 and elsewhere in this Form 10-Q. Investors are urged to consider these factors carefully in evaluating any forward-looking statements and are cautioned not to place undue reliance on such forward-looking statements. The forward-looking statements made herein are only made as of the date hereof, and we undertake no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.

Certain statements in the following discussions are based on non-GAAP financial measures. A “non-GAAP financial measure” is a numerical measure of a registrant’s historical or future financial performance, financial position or cash flows that (i) excludes amounts, or is subject to adjustments that have the effect of excluding amounts, that are included in the most directly comparable measure calculated and presented in accordance with GAAP in the statements of comprehensive income, balance sheets or statements of cash flows of the issuer; or (ii) includes amounts, or is subject to adjustments that have the effect of including amounts, that are excluded from the most directly comparable measure so calculated and presented. The Company includes non-GAAP financial measures in this Management’s Discussion and Analysis, as the Company’s management believes that these measures and the information they provide are useful to investors because they permit investors to view the Company’s performance using the same tools that management uses and to better evaluate the Company’s ongoing business performance. In order to better align the Company’s reported results with the internal metrics used by the Company’s management to evaluate business performance as well as to provide better comparisons to prior periods and peer data, non-GAAP measures exclude the impact of purchase accounting related to the Acquisition. See “Reconciliation of Non-GAAP Revenues” below for more information and reconciliations of such measures to the nearest comparable GAAP measures.

Overview

We are a public sector company that offers a cloud-based suite of solutions primarily for North American state and local governments. Our six wholly-owned subsidiaries are Bonfire, CityBase, eCivis, Open Counter, Questica and Sherpa. Through our operating subsidiaries, we serve some of the fastest growing segments in the government technology sector, specifically procurement, payments, grants management, permitting, and budgeting.

We were formed on August 11, 2016 for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (the “business combination”). Until the business combination, we did not engage in any operations nor generate any revenues. We recognized an opportunity to replace costly legacy on-premises software systems with scalable and efficient SaaS products. Our search led to the acquisition (the “Acquisition”) of Bonfire, CityBase, eCivis, Open Counter, Questica, and Sherpa on February 19, 2019.

Our customers are primarily located in the United States and Canada, including counties, municipalities, special districts, law enforcement agencies and public school districts. We plan to increase our customer base by leveraging our comprehensive product portfolio with our existing customer base, investing in direct sales to new customers, and using relationships with complementary products and services.

We have historically signed a high percentage of agreements with new customers, as well as renewal agreements with existing customers, in the second and third quarters of each year and usually during the last month of the quarter. This can be attributed to buying patterns typical in the public sector. As the terms of most of our customer agreements are measured in full year increments, agreements initially entered into in any given month of any quarter will generally come up for

23

Table of Contents

renewal at that same time in subsequent years. This seasonality is reflected in our invoicing and cash flows with our highest collections occurring in the second and third quarters and lower collections in the first and fourth quarters.

Our variable consideration or usage fee revenue is also dependent on the payment patterns of our customers’ constituents.  Historically, a high percentage of these usage fees have been earned in the second and fourth quarters of each year.  This seasonality is also reflected in our revenues and cash flows during the respective periods.

Expansion and Further Penetration of Our Customer Base.    We employ a strategy that focuses on acquiring new customers and growing our relationships with existing customers over time. We believe that significant opportunity exists for us to acquire new customers as well as expand the use of our platforms by selling additional products and increasing the number of users within our current customers’ organizations.

Investment in Growth.    We plan to continue to invest in our business so that we can capitalize on our market opportunity. We intend to continue to grow our sales and marketing team to acquire new customers and to increase sales to existing customers. We intend to continue to grow our research and development team to extend the functionality and range of our applications. We also intend to invest in new and improved information technology solutions to support our business. However, we expect our sales and marketing expenses and research and development expenses as a percentage of revenues to decrease over time as we grow our revenues and gain economies of scale by increasing our customer base and increase sales to our existing customer base. We believe that these investments will contribute to our long-term growth, although they may adversely affect our profitability in the near term.

Leveraging Relationships.    We plan to continue to strengthen and expand our relationships with technology vendors, professional services firms, and resellers. These relationships enable us to increase the speed of deployment and offer a wider range of integrated services to our customers. We intend to support these existing relationships, seek additional relationships and further expand our channel of resellers to help us increase our presence in existing markets and to expand into new markets. Our business and results of operations will be significantly affected by whether we succeed in leveraging and expanding these relationships.

Market Adoption of Our Platforms.    A key focus of our sales and marketing efforts is creating market awareness about the benefits of our cloud-based SaaS platforms. The market for SaaS solutions is less mature than the market for on-premise software applications, and potential customers may be slow or unwilling to migrate from their legacy solutions. Our business and operating results will be significantly affected by the degree to and speed with which organizations adopt our solutions.

Key Components of our Results of Operations

Revenues

Subscription, support and maintenance. We deliver SaaS and provide customers with access to SaaS-related support and updates during the term of the arrangement. Revenues are recognized ratably over the contract term as the customer simultaneously receives and consumes the benefits of the subscription service. Subscription fees are typically payable within 30 days after the execution of a contract, and thereafter upon renewal. We initially record subscription fees as contract liabilities and recognize revenues on a straight-line basis over the term of the agreement.

Our contracts may include variable consideration in the form of usage fees, which are included in the transaction price in the period in which the usage occurs and the fee is known.

Subscription, support and maintenance revenues also includes kiosk rentals and on-premise support or maintenance pertaining to license sales. Revenues from kiosk rentals and on-premise support are recognized on a straight-line basis over the support period.

Revenues from subscription, support and maintenance comprised approximately 77% and 68% of total revenues for the three months ended March 31, 2021 and 2020, respectively.

24

Table of Contents

Professional services.     Our professional services contracts generate revenues on a time and materials, fixed fee or subscription basis. Revenues are recognized as the services are rendered for time and materials contracts. Revenues are recognized when the milestones are achieved and accepted by the customer or on a proportional performance basis for fixed fee contracts. Revenues are recognized ratably over the contract term for subscription contracts. The milestone method for revenue recognition is used when there is substantive uncertainty at the date the contract is entered into regarding whether the milestone will be achieved. Training revenues are recognized as the services are performed. Revenues from professional services comprised approximately 22% and 28% of total revenues for the three months ended March 31, 2021 and 2020.

License. Revenues from distinct licensed software are recognized upfront when that software is made available to the customer, which normally coincides with contract execution, as this is when the customer has the risks and rewards of the right to use the software. Revenues from licenses comprised approximately less than 1% and 3% of total revenues for the three months ended March 31, 2021 and 2020, respectively.

Asset sales. Revenues from asset sales are recognized when the asset, typically a kiosk, has been received by the customer and is fully operational and ready to accept transactions, which is when the customer obtains control and has the risks and rewards of the asset. Asset sales were approximately 1% and less than 1% of total revenues for the three months ended March 31, 2021 and 2020, respectively.

Cost of Revenues

Cost of revenues primarily consists of salaries and benefits of personnel relating to our hosting operations and support, implementation, and grants research. Cost of revenues includes data center costs including depreciation of the Company’s data center assets, third-party licensing costs, consulting fees, and the amortization of acquired technology from recent acquisitions.

Operating Expenses

Sales and marketing

Sales and marketing expenses consist primarily of personnel costs of our sales and marketing employees, including salaries, sales commissions and incentives and benefits, travel and related costs, outside consulting fees, marketing programs, including lead generation, and costs of advertising and trade shows. We defer sales commissions and amortize them ratably over the expected customer life. We expect that sales and marketing expenses will increase as we expand our direct sales teams and increase sales through our strategic relationships and resellers.

Research and development

Research and development expenses consist primarily of salaries and benefits associated with our engineering, product and quality assurance personnel. Research and development expenses also include the cost of third-party contractors. Other than internal-use software development costs that qualify for capitalization, research and development costs are expensed as incurred. We expect research and development costs to increase as we develop new solutions and make improvements to our existing platforms.

General and administrative

General and administrative expenses consist primarily of salaries and benefits with our executive, finance, legal, human resources, compliance and other administrative personnel, accounting, auditing and legal professional services fees, recruitment costs, and other corporate-related expenses. We expect that general and administrative expenses will increase as we scale our business, but at a lower rate over time.

25

Table of Contents

Results of Operations

Three Months Ended March 31, 2021 Compared to the Three Months Ended March 31, 2020

Total revenues

Our total revenues were $13.3 million for the three months ended March 31, 2021. Excluding the $0.1 million impact of purchase accounting, our total non-GAAP revenues for the three months ended March 31, 2021 was $13.4 million compared to $11.6 million for the three months ended March 31, 2020, representing a 15% increase. This increase was driven by an increase in the number of customers, an increase in the number of users added by existing customers and an increase in the number of products purchased by existing customers. The change in revenues for each operating segment is provided in the following table (in thousands, except percentages):

Generally Accepted Accounting Principles (“GAAP”)

Non-GAAP

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total 

 

Total 

 

Increase /

Increase /

Total 

 

Total

Increase /

Increase /

    

Revenues

Revenues

    

(Decrease)

    

(Decrease) 

    

Revenues 

    

Revenues

    

(Decrease) 

    

(Decrease) 

 

2021

2020

 in Dollars

in %

2021

2020

in Dollars

in %

Procurement

$

2,437

$

1,656

$

781

 

47

%  

$

2,437

1,665

$

772

 

46

%

Payments

 

2,229

 

1,899

 

330

 

17

%  

 

2,351

2,032

 

319

 

16

%

Grants Management

 

1,750

 

1,465

 

285

 

19

%  

 

1,750

1,480

 

270

 

18

%

Permitting

 

695

 

613

 

82

 

13

%  

 

695

613

 

82

 

13

%

Budget

 

6,148

 

5,643

 

505

 

9

%  

 

6,148

5,801

 

347

 

6

%

Total

$

13,259

$

11,276

$

1,983

 

18

%  

$

13,381

$

11,591

$

1,790

 

15

%

A reconciliation of non-GAAP revenues and other non-GAAP financial measures is included in the section titled “Reconciliation of Non-GAAP Financial Measures” in this Quarterly Report on Form 10-Q.

Total cost of revenues

Our total cost of revenues for the three months ended March 31, 2021 increased primarily as a result of headcount additions to support our revenue growth and share-based compensation resulting from the grant of restricted stock units. The change in cost of revenues for each operating segment is due to the following (in thousands, except percentages):

`

    

    

    

    

 

 

Total Cost

 

Total Cost

 

 

 

of 

 

of 

Increase /

Increase /

 

Revenues

 

Revenues

(Decrease)

(Decrease)

2021

2020

in Dollars

 in %

Procurement

$

470

$

392

$

78

 

20

%

Payments

 

1,566

 

1,470

 

96

 

7

%

Grants Management

 

650

 

722

 

(72)

 

(10)

%

Permitting

 

154

 

139

 

15

 

11

%

Budget

 

1,902

 

1,804

 

98

 

5

%

Total

$

4,742

$

4,527

$

215

 

5

%

Procurement

Procurement’s total cost of revenues increased by $0.1 million or 20% primarily due to a $0.1 million or 15% increase in salaries and wages driven by an 8% increase in average headcount from March 31, 2020 to March 31, 2021.

Payments

Payments’ total cost of revenues increased by $0.1 million or 7% primarily due to a $0.1 million increase in hardware costs resulting from an increase in asset sales.  

26

Table of Contents

Grants Management

Grants Management’s total cost of revenues decreased by $0.1 million or 10% primarily due to a $0.1 million decrease in third-party contractors.

Permitting

Permitting’s total cost of revenues was materially consistent year-over-year.

Budget

Budget’s total cost of revenues increased by $0.1 million or 5% primarily due to a $0.1 million increase in share-based compensation related to the issuance of restricted stock units.

Operating expenses (sales and marketing, general and administrative, and research and development)

Our operating expenses (including sales and marketing, general and administrative and research and development expenses) for the three months ended March 31, 2021 have decreased due primarily to the restructuring plan implemented in March 2020. The change in operating expenses for each operating segment is due to the following (in thousands, except percentages):

 

 

Operating

Operating

Increase /

Increase /

 

Expenses

Expenses

(Decrease)

(Decrease)

 

    

2021

    

2020

    

in Dollars

    

in %

 

Procurement

$

2,121

$

2,556

$

(435)

 

(17)

%

Payments

 

3,054

 

5,019

 

(1,965)

 

(39)

%

Grants Management

 

1,732

 

1,869

 

(137)

 

(7)

%

Permitting

 

631

 

937

 

(306)

 

(33)

%

Budget

 

2,646

 

2,991

 

(345)

 

(12)

%

Corporate

 

1,756

 

2,729

 

(973)

 

(36)

%

Total

$

11,940

$

16,101

$

(4,161)

 

(26)

%

Procurement

Procurement’s total operating expense decreased by $0.4 million or 17% primarily due to a $0.3 million or 23% decrease in sales and marketing expenses and a $0.1 million or 13% decrease in research and development.  The decrease in sales and marketing expenses was due primarily to a $0.1 million or 15% decrease in salaries and wages, a $0.1 million decrease in share-based compensation and a $0.1 million decrease in travel and trade shows resulting from the COVID-19 pandemic.  The decrease in salaries and wages was due primarily to a 26% decrease in average headcount from March 31, 2020 to March 31, 2021 driven mainly by our March 2020 restructuring.  The decrease in research and development was primarily due to a $0.1 million or 12% decrease in salaries and wages due to a 29% decrease in average headcount from March 31, 2020 to March 31, 2021.

Payments

Payments’ total operating expense decreased by $2.0 million or 39% primarily due to a $0.7 million or 40% decrease in research and development, a $0.6 million or 48% decrease in sales and marketing expense, and a $0.6 million or 32% decrease in general and administrative expenses.  The decrease in sales and marketing expenses was due primarily to a $0.3 million decrease in share-based compensation and a $0.2 million or 25% decrease in salaries and wages. The decrease in salaries and wages related to sales and marketing was due primarily to a 23% decrease in average headcount from March 31, 2020 to March 31, 2021 driven mainly by our March 2020 restructuring. The $0.6 million decrease in general and administrative expenses was due primarily to a $0.4 million decrease in share-based compensation and a $0.2 million or 26% decrease in salaries and wages resulting from a 28% decrease in average headcount from March 31, 2020 to March 31, 2021. The $0.7 million decrease in research and development was due primarily to a $0.6 million or 39% decrease in

27

Table of Contents

salaries and wages related to a 30% decrease in average headcount from March 31, 2020 to March 31, 2021 and a $0.1 million decrease in share-based compensation.

Grants Management

Grants Management’s total operating expense decreased by $0.1 million or 7% primarily due to a $0.2 million or 34% decrease in general and administrative costs offset by a $0.1 million or 16% increase in sales and marketing expenses. The decrease in general and administrative costs was primarily due to a $0.1 million decrease in human resources and recruiting spend and a $0.1 million decrease in consulting and professional services costs. The increase in sales and marketing costs was primarily driven by a $0.1 increase in third-party commissions.

Permitting

Permitting’s total operating expenses decreased by $0.3 million or 33% primarily due a $0.2 million or 37% decrease in sales and marketing expenses and a $0.1 million or 50% decrease in general and administrative expenses. The decrease in sales and marketing is primarily due to a $0.2 million or 42% decrease in salaries and wages related to a 24% decrease in headcount resulting from the March restructuring. The $0.1 million decrease in general and administrative costs was related to a $0.1 million decrease in travel spend due to the Covid-19 pandemic.

Budget

Budget’s total operating expenses decreased by $0.3 million or 12% primarily due to a $0.2 million or 14% decrease in sales and marketing expenses and a $0.1 million or 16% decrease in general and administrative expenses.  The decrease in sales and marketing expenses is primarily related to a $0.2 million or 18% decrease in salaries and wages related to a 4% decrease in average headcount from March 31, 2020 to March 31, 2021.  The $0.1 million decrease in general and administrative expenses is primarily related to a $0.1 decrease in share-based compensation related to issuance of restricted stock units.

Corporate

Corporate expenses are primarily comprised of outside services including legal, accounting and consulting fees, payroll and related expenses, corporate insurance, and share-based compensation.  Corporate expenses decreased by $1.0 million or 36% due primarily to a $0.5 million decrease in share-based compensation from the cancellation of restricted stock units and a $0.5 million or 62% decrease in salaries and wages.  The decrease in salaries and wages is due primarily to a 41% decrease in average headcount from March 31, 2020 to March 31, 2021 driven mainly by our March 2020 restructuring.  

Other operating expenses

Amortization of intangible assets

Amortization of intangible assets consists of the amortization of finite lived intangibles resulting from the Acquisition as described in Note 4 of the notes to our condensed consolidated financial statements.

Acquisition costs

Acquisition costs consists primarily of Acquisition transaction costs, capital market advisory fees, and bonuses incurred as a result of the transaction or a change in control.

Restructuring costs

On March 30, 2020, the Company implemented a global restructuring plan which resulted in an approximate 10% reduction of the Company’s workforce.  This action was intended to streamline the Company’s operational reporting and reduce operating cash outflows.  The Company recorded pre-tax restructuring charges of approximately $3.5 million which

28

Table of Contents

was comprised of one-time employee termination benefits paid over a weighted average period of approximately 10 months.  

Change in fair value of contingent consideration

The change in fair value of contingent consideration consists of any adjustments to the contingent consideration liability since the Acquisition.

Other income (expense)

Interest income (expense)

Interest income (expense) is primarily comprised of the investments held by GTY Corporate offset by interest under the November 2020 Credit Facility.

Loss on repurchase/issuance of shares

Loss on repurchase/issuance of shares is comprised of the difference in fair value between the price in which shares are issued and the market value on the date of grant.

Change in fair value of warrant liability

Change in fair value between the current price of the Company’s warrants and the previously reported price.

Other income (loss)

Other income (loss) is comprised primarily of unrealized gains and losses associated with transactions in currencies that are not denominated in U.S. Dollars.

Reconciliation of Non-GAAP Revenues

To supplement our condensed consolidated financial statements, which are prepared in accordance with U.S. generally accepted accounting principles, or GAAP, we have provided certain financial measures that have not been prepared in accordance with GAAP (“non-GAAP financial measures”), which include (i) non-GAAP revenues, (ii) non-GAAP gross profit and non-GAAP gross margin and (iii) non-GAAP loss from operations.

We use these non-GAAP financial measures internally in analyzing our financial results and believe that these metrics are useful to investors, as a supplement to the corresponding GAAP measure, in evaluating our ongoing operational performance and trends. However, it is important to note that particular items we exclude from, or include in, our non-GAAP financial measures may differ from the items excluded from, or included in, similar non-GAAP financial measures used by other companies in the same industry. Non-GAAP financial measures should not be considered in isolation from, or as a substitute for, financial information prepared in accordance with GAAP. Investors are encouraged to review the reconciliation of these non-GAAP financial measures to their most directly comparable GAAP financial measures.

Non-GAAP Revenues. Non-GAAP revenues are defined as GAAP revenues adjusted for the impact of purchase accounting resulting from a company’s business combination which reduced its acquired contract liabilities to fair value. The Company believes that presenting non-GAAP revenues is useful to investors as it eliminates the impact of the purchase accounting adjustments to revenues to allow for a direct comparison between current and future periods.

Non-GAAP Gross Profit and Non-GAAP Gross Margin. Non-GAAP gross profit is defined as GAAP gross profit adjusted for the impact of purchase accounting resulting from a company’s business combination and share-based compensation included in cost of revenues. Non-GAAP gross margin is defined as non-GAAP gross profit divided by non-GAAP revenues. The Company believes that presenting non-GAAP gross profit and margin is useful to investors as it eliminates the impact of the purchase accounting adjustments to allow for a direct comparison between periods.

29

Table of Contents

Non-GAAP Loss from Operations. Non-GAAP loss from operations is defined as GAAP loss from operations adjusted for the impact of purchase accounting to revenues resulting from a company’s business combination, the amortization of acquired intangible assets, share-based compensation, acquisition related costs, goodwill impairment expense, restructuring charges and the change in fair value of contingent consideration. The Company believes that presenting non-GAAP loss from operations is useful to investors as it eliminates the impact of certain non-cash and acquisition related expenses to allow a direct comparison of loss from operations between all periods presented.

Below is a reconciliation of non-GAAP revenues, non-GAAP gross profit and non-GAAP gross margin and non-GAAP loss from operations to their most directly comparable GAAP financial measures (in thousands, except percentages):

Three Months Ended

 

March 31, 

December 31,

March 31, 

 

    

2021

    

2020

    

2020

 

Revenues

$

13,259

$

13,101

$

11,276

 

Purchase accounting adjustment to revenue

122

126

315

 

Non-GAAP Revenues

 

$

13,381

$

13,227

$

11,591

Gross Profit

 

$

8,517

$

8,174

$

6,749

Purchase accounting adjustment to revenue

122

126

315

Share-based compensation

292

236

218

Non-GAAP Gross Profit

 

$

8,931

$

8,536

$

7,282

Gross Margin

64

%

62

%

60

%

Non-GAAP Gross Margin

67

%

65

%

63

%

Loss from operations

 

$

(8,136)

$

(11,125)

$

(16,520)

Purchase accounting adjustment to revenue

122

126

315

Amortization of intangibles

3,599

3,683

3,673

Share-based compensation

1,823

2,283

3,295

Goodwill impairment expense

2,000

Restructuring charges

3,466

Change in fair value of contingent consideration

1,114

1,951

29

Non-GAAP Loss from operations

 

$

(1,478)

$

(1,082)

$

(5,742)

30

Table of Contents

Three Months Ended March 31, 

 

    

2021

    

2020

 

Revenues

 

13,259

 

11,276

Purchase accounting adjustment to revenue

 

122

 

315

Non-GAAP Revenues

$

13,381

$

11,591

Gross Profit

 

8,517

6,749

Purchase accounting adjustment to revenue

 

122

315

Share-based compensation

292

218

Non-GAAP Pro forma as Adjusted Gross Profit

$

8,931

$

7,282

Gross Margin

 

64

%  

 

60

%  

Non-GAAP Gross Margin

 

67

%  

 

63

%  

Loss from operations

$

(8,136)

$

(16,520)

Purchase accounting adjustment to revenue

 

122

 

315

Amortization of intangibles

 

3,599

 

3,673

Share-based compensation

 

1,823

 

3,295

Restructuring charges

3,466

Change in fair value of contingent consideration

 

1,114

 

29

Non-GAAP Loss from operations

$

(1,478)

$

(5,742)

Below is a reconciliation of non-GAAP revenues to revenues by operating segment:

Three Months Ended March 31, 

Grants

Total

    

Procurement

    

Payments

    

Management

    

Permitting

    

Budget

    

Revenues

 

Revenues 2021

$

2,437

$

2,229

$

1,750

$

695

$

6,148

$

13,259

Purchase accounting adjustment to revenues

122

122

Non-GAAP Revenues 2021

$

2,437

$

2,351

$

1,750

$

695

$

6,148

$

13,381

 

Revenues 2020

$

1,656

$

1,899

$

1,465

$

613

$

5,643

$

11,276

Purchase accounting adjustment to revenues

 

9

 

133

 

15

 

 

158

 

315

Non-GAAP Revenues 2020

$

1,665

$

2,032

$

1,480

$

613

$

5,801

$

11,591

% change

 

46

%  

 

16

%  

 

18

%  

 

13

%  

 

6

%  

 

15

%

Liquidity and Capital Resources

As of March 31, 2021, we had a cash balance of approximately $17.9 million. From the date of the Acquisition through  March 31, 2021, our liquidity needs have been satisfied through proceeds from the January–February 2020 PIPE transactions, proceeds from our initial public offering that were released in February 2019 from the trust account established in connection such offering for the benefit of our shareholders, proceeds from our June 2019 registered direct offering, proceeds from our February 2020 and November 2020 credit facilities, proceeds from issuance of stock under our ATM agreement, and loan proceeds in April–May 2020 from the Paycheck Protection Program.

Our unaudited condensed consolidated financial statements have been prepared assuming that we will continue as a going concern, which contemplates continuity of operations, realization of assets, and liquidation of liabilities in the normal course of business.

31

Table of Contents

We are attempting to further expand our customer base, scale up production of various products; and increase revenues; however, our cash position may not be sufficient to support our daily operations through the next twelve months from the date of filing this 10-Q. Our ability to continue as a going concern is dependent upon our ability to raise additional funds by way of a public or private offering and our ability to further generate sufficient revenues. While we believe in the viability of our platforms, and in our ability to raise additional funds by way of a public or private offering, there can be no assurances to that effect.

COVID-19 Update

In December 2019, the emergence of a novel coronavirus, or COVID-19, was reported and in March 2020, the World Health Organization, or WHO, characterized COVID-19 as a pandemic. We responded by immediately restricting non-essential travel and enabled work-from-home protocols. Shortly thereafter, and in line with guidance provided by government agencies and international organizations, we restricted all travel, mandated a work-from-home policy across our global workforce, and moved all in-person customer-facing events to virtual ones. We expect these restrictions to stay in effect during the second quarter of 2021. We also responded by launching the GTY COVID Emergency Response Program, where a number of GTY products were offered free for a few months to allow our customers to move quickly to solve their infrastructure problems and prevent interruption to government services.

As a result of the pandemic, we have seen purchasing decisions being deferred or delayed, delays in services revenue due to the delayed implementation of projects, and an impact on new business pipeline and large deals. We have also seen a decrease in travel-related expenses and advertising and trade show expenses.  We expect to see similar impacts in 2021.

The broader implications of the global emergence of COVID-19 on our business, operating results, and overall financial performance remain uncertain and they depend on certain developments, including the duration and spread of the outbreak, impact on our customers and our sales cycles, impact on our partners or employees, and impact on the economic environment and financial markets, all of which are uncertain and cannot be predicted. We are conducting business as usual with certain limitations to employee travel, employee work locations, and marketing events, among other modifications. We have observed other companies taking precautionary and preemptive actions to address COVID-19, and the effects it has had and is expected to have on business and the economy. Since March 2020, we have seen certain new and existing customers halt or decrease investment in infrastructure, and we expect that certain of our current and potential customers will take actions to reduce operating expenses and moderate cash flows, including by delaying sales and requesting extended billing and payment terms. We will continue to actively monitor the situation and may take further actions that alter our business operations, as may be required by federal, state, or local authorities, or that we determine are in the best interests of our employees, customers, partners, suppliers, and stockholders.

Historical Cash Flows

The following table sets forth a summary of our cash flows for the periods indicated:

Three Months Ended

Three Months Ended

March 31, 

March 31, 

    

2021

  

2020

  

Net cash used in operating activities

$

(3,406)

$

(10,269)

Net cash used in investing activities

$

(31)

$

(1,111)

Net cash provided by (used in) financing activities

$

(1,418)

$

11,317

Net Cash Used In Operating Activities

Our net loss and cash flows from operating activities are significantly influenced by the Acquisition and our investments in headcount and infrastructure to support anticipated growth.

For the three months ended March 31, 2021, net cash used in operations was $(3.4) million resulting from our net loss of $18.0 million and changes in operating assets and liabilities of $1.7 million, offset by net non-cash expenses of $16.4 million. The $16.4 million of non-cash expenses was comprised of a $5.3 million loss associated with the redemption of

32

Table of Contents

common stock, $4.0 million change in fair value of warrant liability, $3.6 million of amortization of intangible assets acquired as a result of the Acquisition, $1.8 million from share-based compensation resulting from our issuance of stock options and restricted stock units and a $1.1 million change in contingent consideration, offset by $0.2 million of deferred tax benefits related to the tax and book basis difference on the amortization of intangible assets and $0.2 million gain on extinguishment of debt. The changes in operating assets and liabilities of $(1.7) million was comprised primarily of a $1.5 million increase in prepaid expenses and other assets, a $0.8 million decrease in accounts payable and accrued liabilities, and a $0.8 million increase in accounts receivable, offset by a $1.7 million increase in deferred revenue and other long-term liabilities.


For the three months ended March 31, 2020, net cash used in operations was $10.3 million resulting from our net loss of $17.4 million and changes in operating assets and liabilities of $1.6 million and offset by net non-cash expenses of $8.7 million. The $8.7 million of non-cash expenses was comprised of $3.7 million of amortization of intangible assets acquired as a result of the Acquisition, a $3.3 million from share-based compensation, a $2.1 million loss on issuance of shares, and $1.6 million change in fair value of warrant liability, and offset by $2.5 million of deferred tax benefits related to the tax and book basis difference on the amortization of intangible assets. The changes in operating assets and liabilities of $1.6 million was comprised primarily of a $1.1 million increase in prepaid expenses and other assets associated with the payments for insurance premiums, letters of credit required by certain customers and software subscription payments.

Net Cash Used In Investing Activities

Our primary investing activities have consisted of capital expenditures.

For the three months ended March 31, 2021, cash used in investing activities was less than $0.1 million resulting from capital expenditures.

For the three months ended March 31, 2020, cash used in investing activities was $1.1 million resulting from $1.1 million of capital expenditures associated with lease improvements and furniture purchases at Questica’s new facility.

Net Cash Provided By (Used in) Financing Activities

For the three months ended March 31, 2021, cash used in financing activities was $(1.4) million primarily due to $8.0 million in redemptions of common shares offset by $6.8 million in proceeds from the issuance of common stock.


For the three months ended March 31, 2020, cash provided by financing activities was $11.3 million primarily due to $11.5 million of proceeds from the issuance of our term loan, net of issuance costs and offset by $0.2 million in repayments of finance lease obligations and contingent consideration payments.

Critical Accounting Policies and Use of Estimates

See Note 3 of the notes to our unaudited condensed consolidated financial statements.

Recent Accounting Pronouncements

The impact of recently issued accounting standards is set forth in Note 3, Summary of Significant Accounting Policies, of the notes to our condensed consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q.

Off-Balance Sheet Arrangements

We are not party to any off-balance sheet transactions. We have no guarantees or obligations other than those which arise out of normal business operations.

33

Table of Contents

Contractual Obligations and Commitments

As of March 31, 2021, there were no significant changes to our contractual obligations from those presented as of December 31, 2020 in our Current Report on Form 10-K filed with the SEC on February 19, 2021.

Item 3.   Quantitative and Qualitative Disclosures About Market Risks

During the three months ended March 31, 2021, there were no material changes to our interest rate risk disclosures, market risk disclosures and foreign currency exchange rate risk disclosures reported in our Current Report Form 10-K filed with the SEC on February 19, 2021 for the year ended December 31, 2020.

Item 4.   Controls and Procedures

Evaluation of Disclosure Controls and Procedures

We maintain “disclosure controls and procedures,” as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), that are designed to ensure that information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in Securities and Exchange Commission rules and forms, and that such information is accumulated and communicated to our management, including our Principal Executive Officer and our Principal Financial Officer, to allow timely decisions regarding required disclosure.

The design of any disclosure controls and procedures also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.

With respect to the quarter ended March 31, 2021, under the supervision and with the participation of our management, we conducted an evaluation of the effectiveness of the design and operations of our disclosure controls and procedures. Based upon this evaluation, the Company’s Principal Executive Officer and Principal Financial Officer have concluded that the Company’s disclosure controls and procedures are effective.

Internal Control over Financial Reporting

Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Exchange Act Rules 13a-15(f) and 15d-15(f). Our internal control system was designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of the consolidated financial statements for external purposes in accordance with generally accepted accounting principles.

During the quarter ended March 31, 2021 and in response to the SEC Statement on April 12, 2021, the Company has identified a material weakness associated with its accounting for warrants.  The Company inappropriately relied upon the broad consensus among special purpose acquisition companies that these warrants were subject to equity treatment under a fixed accounting model.  However, consistent with the SEC Statement, the Company revised its historical financial statements to account for the private warrants as liabilities.  The Company is in the process of implementing new policies to remediate the material weakness mainly the adoption of new policies and procedures associated with the accounting of non-routine and complex transactions.

Changes in Internal Control over Financial Reporting

We are taking actions to remediate the material weakness relating to our internal control over financial reporting, as described above.  Except as otherwise described herein, there was no change in our internal control over financial reporting that occurred during the period covered by this Quarterly Report on Form 10-Q that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

34

Table of Contents

Notwithstanding the identified material weaknesses, management has concluded that the consolidated financial statements included in this quarterly report on Form 10-Q present fairly, in all material respects, the Company's financial position, results of operations and cash flows for the periods disclosed in conformity with U.S. generally accepted accounting principles (U.S. GAAP).

PART II. OTHER INFORMATION

Item 1.Legal Proceedings

On March 19, 2021, the Company received a request from the Securities and Exchange Commission (the “SEC”) for documents relating to the Company’s business combination consummated on February 19, 2019 and related transactions, including those described in a Form 8-K filed by the Company on February 14, 2019.  The Company is cooperating in the SEC’s investigation and intends to continue to do so.

Item 1A.Risk Factors

The reader should carefully consider, in connection with the other information in this Quarterly Report on Form 10-Q, the factors discussed in the section entitled “Risk Factors” of our 2020 Annual Report on Form 10-K.  These factors could cause our actual results to differ materially from those stated in forward-looking statements contained in this document and elsewhere.

Item 2.Unregistered Sales of Equity Securities and Use of Proceeds from Registered Securities

None

35

Table of Contents

Item 6.Exhibits.

Exhibit Number

    

Description

10.1

Amended and Restated Employment Agreement dated April 15, 2021 between the Company and David Farrell.

10.2

Amended and Restated Employment Agreement dated April 29, 2021 between the Company and John Curran.

31.1

Certification of Chief Executive Officer (Principal Executive Officer) Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2

Certification of Chief Financial Officer (Principal Financial Officer) Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1

Certification of Chief Executive Officer (Principal Executive Officer) Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

32.2

Certification of Chief Financial Officer (Principal Financial Officer) Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101.INS

Inline XBRL Instance Document

101.SCH

Inline XBRL Taxonomy Extension Schema Document

101.CAL

Inline XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF

Inline XBRL Taxonomy Extension Definition Linkbase Document

101.LAB

Inline XBRL Taxonomy Extension Label Linkbase Document

101.PRE

Inline XBRL Taxonomy Extension Presentation Linkbase Document

104

Cover Page Interactive Data File (formatted as Inline XBRL and contained in exhibit 101)

36

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized on this 13th day of May, 2021.

GTY TECHNOLOGY HOLDINGS INC.

   

/s/ TJ Parass

Name:

TJ Parass

Title:

Chief Executive Officer

(Principal Executive Officer)

/s/ John Curran

Name:

John Curran

Title:

Chief Financial Officer

(Principal Financial Officer)

37

Exhibit 10.1

GRAPHIC

GTY Technology Holdings Inc

April 15, 2021

David Farrell

Re: Amended and Restated Offer of Employment

Dear David:

On behalf of GTY Technology Holdings Inc. (together with its successors, the “Company”), I am pleased to offer you the amended and restated terms and conditions of your employment with the Company in the position of Chief Operating Officer of the Company and Chief Executive Officer of Sherpa Government Solutions LLC (“Sherpa”), working out of Sherpa’s principal offices in Denver, Colorado.

The terms that will apply to your continuing employment with the Company are as follows:

1.

Position and Duties. Commencing on April 15, 2021 (the “Effective Date”), you will be employed by the Company hereunder on a full-time basis as Chief Operating Officer of the Company and as the Chief Executive Officer of Sherpa, reporting to the Chief Executive Officer of the Company (the “Company CEO”).

You agree to perform the duties and responsibilities of your positions, and such other duties and responsibilities as shall from time to time be mutually agreed upon between you and the Company CEO. You agree that, while employed by the Company, you will devote your full business time and your reasonable efforts, business judgment, skill and knowledge exclusively to the advancement of the business and interests of the Company and its subsidiaries; provided, however, you will be permitted to (i) engage in charitable and civic activities; (ii) manage your personal and family financial matters; and (iii) participate in the business activities in which you currently are participating listed on Annex A attached to the Amended and Restated Fair Competition Agreement between you and the Company dated as of the date hereof (the “Fair Competition Agreement”), in each case, to the extent such activities do not individually or in the aggregate interfere with your duties and responsibilities to the Company or create any actual or potential conflict of interests with the Company’s business.

2.

Base Salary, Annual Bonus and Signing Bonus. During your continuing employment with the Company, you will receive an initial base salary of $350,000, less applicable tax and other withholdings and deductions required by law, payable in accordance with the Company’s payroll practices in effect from time to time. Your base salary will be subject to periodic review by the Compensation Committee (the “Committee”) of the Company’s Board of Directors (the “Board”); provided, that your base salary shall not be decreased without your prior, written consent.


For each calendar year of your continuing employment, you will be eligible to receive an annual cash incentive bonus (the “Annual Bonus”). The target amount of the Annual Bonus will be equal to 50% of your Base Salary. The Annual Bonus will be subject to pro-ration for any period of employment of less than a full calendar year. The Annual Bonus will be subject to the achievement of performance goals established by the Committee. The actual amount of the Annual Bonus, if any, which may be in excess of the target amount if achievement exceeds performance goals, will be determined based on the discretion and recommendation of the Committee to the Board. You must be employed by the Company on the day that the Annual Bonus (if any) for a calendar year is paid in order to earn and receive such Annual Bonus. Any earned Annual Bonus shall be subject to standard payroll deductions and withholdings, and paid no later than March 15th of the year following the calendar year to which the Annual Bonus relates.

The Company shall pay you a lump-sum cash signing bonus of $1,917.18 within 60 days following the Effective Date.

3.

Equity Compensation. You will, subject to the approval by the Administrator of the GTY Technology Holdings Inc. Amended and Restated 2019 Omnibus Incentive Plan (or any other incentive plan adopted or approved by the Company) (the “Incentive Plan”) and continuing employment with the Company, be granted the following equity awards pursuant to the terms and conditions of an award agreement and the Incentive Plan (the “Equity Awards”):

a.

Time-Based Restricted Stock Units.

·

On April 30, 2021, 54,000 time-based restricted stock units, vesting 100% on January 1, 2022.

·

On or before December 31, 2021, 30,000 time-based restricted stock units, vesting in three equal installments on February 19, 2022, February 19, 2023 and February 19, 2024.

·

On or before December 31, 2022, 30,000 time-based restricted stock units, vesting in three equal installments on February 19, 2023, February 19, 2024 and February 19, 2025.

·

On or before December 31, 2023 and the end of each subsequent year, time-based restricted stock units with a fair market value (as defined in the Incentive Plan, Fair Market Value) of $150,000 on the date of grant, rounded up to avoid a grant of fractional shares, vesting in three equal installments on February 19 of each subsequent year.

b.

Performance-Based Restricted Stock Units.

·

On or before December 31, 2021, 55,000 performance-based restricted stock units, vesting in three equal installments on February 19 of each subsequent year subject to the achievement of performance goals established by the Committee.

2


·

On or before December 31, 2022, 55,000 performance-based restricted stock units, vesting in three equal installments on February 19 of each subsequent year subject to the achievement of performance goals established by the Committee.

·

On or before December 31, 2023 and the end of each subsequent year, performance-based restricted stock units with a Fair Market Value of $275,000 on the date of grant, rounded up to avoid a grant of fractional shares, vesting in three equal installments on February 19 of each subsequent year subject to the achievement of performance goals established by the Committee.

c.

Long-Term Incentive Plan.

·

On or before December 31, 2022, a grant of performance-based restricted stock units with a Fair Market Value of $1,000,000 on the date of grant, rounded up to avoid a grant of fractional shares, vesting in three equal installments on February 19 of each subsequent year subject to the achievement of performance goals established by the Committee related to revenue and shareholder value.

·

On or before December 31, 2024, a grant of performance-based restricted stock units with a Fair Market Value of $1,000,000 on the date of grant, rounded up to avoid a grant of fractional shares, vesting in three equal installments on February 19 of each subsequent year subject to the achievement of performance goals established by the Committee related to revenue and shareholder value.

4.

Benefit Plans and Programs. You will be eligible to participate in the Company’s or Sherpa’s benefits and benefits plans and programs in effect from time to time for similarly situated executives, subject to the terms of any and all plan documents. The Company reserves the right, in its sole discretion, to amend, change or discontinue, in whole or in part, any and all of its benefits and/or benefit plans and programs, at any time for any reason. The Company will reimburse you for all reasonable business expenses you incur in the performance of your duties, subject to the terms of the Company’s expense reimbursement policies in effect from time to time applicable to senior executives. You will be entitled to the benefits of GTY’s Flexible Paid Time Off Policy and, in any event, no less than 20 days’ paid vacation in accordance with the Company’s policies.

5.

At-Will Employment. Your employment with the Company shall, at all times, be on an “at-will” basis. This means that your employment is not for a fixed term or definite period. Rather, your employment can be terminated at any time, for any or no reason, with or without cause or notice, and you may resign at any time with or without reason, subject to any notice you are required to provide pursuant to the terms of the Fair Competition Agreement between you and the Company. The at-will nature of the employment relationship cannot be changed except in a separate, individualized, written agreement signed by you and the Company.

6.

Termination. In the event your employment with the Company terminates for any reason, the Company will pay you (i) unpaid base salary through the termination date, payable in accordance with the Company’s payroll practices, (ii) unreimbursed business expenses,

3


payable in accordance with and subject to the terms of the Company’s expense reimbursement policies and (iii) any vested non-forfeitable amounts owing or accrued as of the termination date under the Company’s benefit plans or programs in which you participated (collectively, the “Accrued Benefits”).

Without otherwise limiting the “at-will” nature of your employment, in the event your employment is terminated at any time by the Company without “Cause” (as defined below) or by you for “Good Reason” (as defined below), then the Company shall provide you the following payments and benefits (the “Severance Benefits”): (1) an amount (the “Cash Severance”) equal to the sum of 1.5 times your then-current annual base salary plus 1.5 times your then-current target Annual Bonus, payable in substantially equal installments over the 18-month period following the date of your termination (the “Severance Period”); and (2) provided you timely elect and remain eligible for coverage pursuant to Part 6 of Title I of ERISA, or similar state law (collectively, “COBRA”), payment or reimbursement to you of an amount equal to the full monthly premium for COBRA continuation coverage under the Company’s medical plans as in effect on the date of your termination with respect to the level of coverage in effect for you and your eligible dependents as of the date of your termination, on a monthly basis on the first business day of the calendar month next following the calendar month in which the applicable COBRA premiums were paid, with respect to the period from the date of your termination until the earlier of (x) 18 months following such date and (y) the date you become eligible for continued coverage under a subsequent employer’s health plan; and (3) any unvested or partially vested Equity Awards shall become fully vested; provided, that, notwithstanding the foregoing, the Equity Awards referenced in Section 3.c. (Long Term-Incentive Plan) shall vest only if and to the extent that they would have vested within six months following the date on which your employment is terminated by the Company without “Cause” or by you for “Good Reason”.

Notwithstanding anything herein to the contrary, you will not be entitled to receive the Severance Benefits or any other payment or benefit triggered upon termination of employment (other than the Accrued Benefits) unless, within 30 days following the termination date, you, or in the event of your death or Disability, your legal representatives, have executed and not revoked a general release of claims in the standard form utilized by the Company for similarly-situated employees (the “Release”). The Severance Benefits shall be paid or commence on the first payroll period following the date the Release becomes effective and the vesting of the Equity Awards if and as provided in this Section 5 shall occur on such date (the “Payment and Vesting Date”), provided that if the period during which you may deliver the Release spans two calendar years, the Payment and Vesting Date shall be no earlier than January 1 of the second calendar year.

For purposes of this amended and restated offer letter (this “offer letter”), “Cause” shall mean: (i) a willful act of dishonesty by you in connection with the performance of your duties as an employee; (ii) your conviction of, indictment for, or plea of guilty or nolo contendere to, a felony or any crime involving fraud, embezzlement or moral turpitude, or a material violation of federal or state law that the Board reasonably determines has had or is reasonably likely to have a detrimental effect on the Company’s reputation or business; (iii) your gross misconduct in the performance of your duties as an employee; (iv) your intentional or grossly

4


negligent unauthorized use or disclosure of any Confidential Information or Intellectual Property (each as defined in the Fair Competition Agreement); (v) your material breach of any obligations under any written agreement between you and the Company, including, without limitation, the Fair Competition Agreement; (vi) your breach of any material Company policy communicated to you, including but not limited to those relating to insider trading or sexual harassment; or (vii) your willful refusal to follow the reasonable, lawful directives of the Board.

For purposes of this offer letter, “Good Reason” shall mean (i) a material diminution in your base salary or target Annual Bonus opportunity; (ii) a material diminution in your duties as Chief Operating Officer of the Company; (iii) a relocation of your principal work location to a facility or a location more than 30 miles from your principal work location on the Effective Date or (iv) a requirement that you report to any officer of the Company other than the Chief Executive Officer. A resignation for Good Reason will not be deemed to have occurred unless you give the Company written notice of the condition within 90 days after the condition initially comes into existence, the Company fails to remedy the condition within 30 days after receiving your written notice and you actually resign your employment within 60 days following the expiration of the Company’s cure period.

7.

Fair Competition Agreement. As a material inducement for the Company to agree to enter into an employment relationship with you on the terms set forth herein, you agree to execute and comply with the Fair Competition Agreement attached hereto as Exhibit A.

8.

Company Policies and Procedures. Your employment will be subject to the Company’s standard policies and procedures (whether as currently existing or to be established in the future), as they may be amended, changed or discontinued at any time and such other rules and regulations as may be adopted or amended in the Company’s sole discretion.

9.

Section 409A. The Severance Benefits and other payments under this offer letter triggered on a termination of employment shall begin only after the date of your “separation from service” (determined as set forth below), which occurs on or after date of the termination of your employment, and shall be subject to the provisions of this Section 9. The intent of the parties is that payments and benefits under this offer letter comply with, or are exempt from, Section 409A of the Internal Revenue Code of 1986, as amended (the “Code”), and the regulations and guidance promulgated thereunder (collectively, “Section 409A”) and, accordingly, to the maximum extent permitted, this offer letter shall be interpreted to be in compliance therewith. For purposes of Section 409A, your right to receive any installment payments pursuant to this offer letter will be treated as a right to receive a series of separate payments. Neither the Company nor you shall have the right to accelerate or defer the delivery of any such payments except to the extent specifically permitted or required by Section 409A.

If, as of the date of your “separation from service” from the Company, you are not a “specified employee” (within the meaning of Section 409A), then each installment of the severance payments shall be made on the dates and terms set forth in this offer letter. If, as of the date of your “separation from service” from the Company, you are a “specified

5


employee” (within the meaning of Section 409A), then: (i) each installment of the Severance Benefits that, in accordance with the dates and terms set forth in this offer letter, will in all circumstances, regardless of when the “separation from service” occurs, be paid within the short-term deferral period (as defined in Section 409A) shall be treated as a “short-term deferral” within the meaning of Treasury Regulation Section 1.409A-l(b)(4) to the maximum extent permissible under Section 409A and shall be paid on the dates and terms set forth in this offer letter; and (ii) each installment of the Severance Benefits that is not described in clause (i) above and that would, absent this clause (ii), be paid within the six-month period following your “separation from service” from the Company shall not be paid until the date that is six months and one day after such “separation from service” (or, if earlier, your death), with any such installments that are required to be delayed being accumulated during the six-month period and paid in a lump sum on the date that is six months and one day following your “separation from service” and any subsequent installments, if any, being paid in accordance with the dates and terms set forth in this offer letter; provided, however, that the preceding provisions of this clause (ii) shall not apply to any installment of the Severance Benefits if and to the maximum extent that that such installment is deemed to be paid under a separation pay plan that does not provide for a deferral of compensation by reason of the application of Treasury Regulation 1.409A- l(b)(9)(iii) (relating to separation pay upon an involuntary separation from service). Any installments that qualify for the exception under Treasury Regulation Section 1.409A- l(b)(9)(iii) must be paid no later than the last day of your second taxable year following the taxable year in which the “separation from service” occurs.

The determination of whether and when your “separation from service” from the Company has occurred shall be made in a manner consistent with, and based on the presumptions set forth in, Treasury Regulation Section l.409A-1(h). Solely for purposes of this paragraph, “Company” shall include all persons with whom the Company would be considered a single employer under Section 414(b) and 414(c) of the Code.

All reimbursements and in-kind benefits provided under this offer letter shall be made or provided in accordance with the requirements of Section 409A to the extent that such reimbursements or in-kind benefits are subject to Section 409A, including, where applicable, the requirements that (1) any reimbursement is for expenses incurred during your lifetime (or during a shorter period of time specified in this offer letter), (2) the amount of expenses eligible for reimbursement during a calendar year may not affect the expenses eligible for reimbursement in any other calendar year, (3) the reimbursement of any eligible expense will be made on or before the last day of the calendar year following the year in which the expense is incurred, and (4) the right to reimbursement is not subject to set off or liquidation or exchange for any other benefit.

Notwithstanding any other provision of this offer letter, the Company makes no representation or warranty and shall have no liability to you or to any other person if any provisions of this offer letter are determined to constitute deferred compensation subject to Section 409A but do not satisfy an exemption from, or the conditions of, that section. If either you or the Company reasonably determines that any payment to you will violate Section 409A, you and the Company agree to use reasonable best efforts to restructure the payment

6


in a manner that is either exempt from or compliant with Section 409A to the extent that the restructuring is consistent with the original economic intent of the parties. You and the Company agree to execute any and all amendments to this offer letter (or any other applicable agreement) that are consistent with the original economic intent of the parties and promote compliance with the distribution provisions of Section 409A in an effort to avoid or minimize, to the extent allowable by law, the tax (and any interest or penalties thereon) associated with Section 409A. If it is determined that a payment to you was (or may be) made in violation of Section 409A, the Company will cooperate, to the extent commercially reasonable, with any effort by you to mitigate the tax consequences of such violation, including cooperation with your participation in any IRS voluntary compliance program or other correction procedure under Section 409A that may be available to you; provided, that such correction is consistent with the commercial intent of the parties hereunder; provided, further, that in no event shall the Company be obligated to incur any material cost in connection with its obligations under this sentence.

10.

Section 280G. Notwithstanding any other provision of this letter or any other plan, arrangement or agreement to the contrary, if any of the payments or benefits provided or to be provided by the Company, Sherpa or any of their affiliates to you or for your benefit pursuant to the terms of this letter or otherwise (“Covered Payments”) constitute “parachute payments” within the meaning of Section 280G of the Code, and would, but for this paragraph be subject to the excise tax imposed under Section 4999 of the Code (or any successor provision thereto) or any similar tax imposed by state or local law or any interest or penalties with respect to such taxes (collectively, the “Excise Tax”), then the Covered Payments shall be reduced (but not below zero) to the minimum extent necessary to ensure that no portion of the Covered Payments is subject to the Excise Tax. Any such reduction shall be made by the Company in its sole discretion consistent with the requirements of Section 409A. Any determination required under this paragraph, including whether any payments or benefits are parachute payments, shall be made by the Company in its sole discretion. You shall provide the Company with such information and documents as the Company may reasonably request in order to make a determination under this paragraph. The Company’s determinations shall be final and binding on the Company and you.

11.

Notices. All notices or other communications required or permitted to be given under this offer letter shall be in writing and shall be deemed to have been duly given when delivered personally or one business day after being sent by a nationally recognized overnight delivery service, charges prepaid. Notices also may be given electronically via PDF and by email and shall be effective on the date transmitted if confirmed within 48 hours thereafter by a signed original sent in the manner provided in the preceding sentence. Notice to you shall be sent to your most recent residence and personal email address on file with the Company. Notice to the Company shall be sent to its physical address set forth on the first page hereto and addressed to the Board or such other person as the Company may designate at the email address provided by the Company for the Board or such person.

12.

Entire Agreement; Miscellaneous. This offer letter, together with the Incentive Plan, any equity award agreements referenced herein and the Fair Competition Agreement, constitutes the entire agreement and understanding between the parties as to the subject matter herein

7


and supersedes all prior or contemporaneous agreements whether written or oral including, but not limited to, the original offer letter dated September 12, 2018. In the event of any conflict between the terms of this offer letter and any of the foregoing documents, the terms of this offer letter shall govern. The terms of this offer letter may only be modified in a specific writing signed by you and an authorized representative of the Company. The invalidity or unenforceability of any provision or provisions of this offer letter will not affect the validity or enforceability of any other provision hereof, which will remain in full force and effect. Any disputes arising out of or related to this offer letter or your employment with the Company will be subject to the dispute resolution provisions in the Fair Competition Agreement, and this offer letter shall be governed by and construed in accordance with the governing law provision set forth in the Fair Competition Agreement. In the event of any conflict between any of the terms in this offer letter and the terms of any other agreement between you and the Company, the terms of this offer letter will control. By entering into this offer letter and commencing employment with the Company, you represent that you are not bound by any employment contract, restrictive covenant or other restriction that prevents you from entering into employment with or carrying out your responsibilities for the Company, or which is in any way inconsistent with this offer letter. This offer letter is binding on and may be enforced by the Company and its successors and assigns and is binding on and may be enforced by you and your heirs and legal representatives. In addition, the Company may assign this offer letter or any and all rights, duties and obligations hereunder to any subsidiary of the Company, including, without limitation, Sherpa; provided, that the Company hereby unconditionally guarantees full payment of any payment obligations hereunder in the event of such assignment; provided, further, that any payment made by any such assignee shall offset any payment obligation of the Company. This offer letter may be executed in any number of counterparts, all of which taken together shall constitute one instrument. Execution and delivery of this offer letter by facsimile or other electronic signature is legal, valid and binding for all purposes.

[Remainder of page intentionally left blank]

8


We are very excited about your continued employment with the Company and I anticipate that you will make many more important contributions to the Company and its strategic mission. Please acknowledge your acceptance of this amended and restated offer by returning a signed copy of this amended and restated offer letter.

Very truly yours,

GTY Technology Holdings Inc.

By:

/s/ TJ Parass

Name:

TJ Parass

Title:

Chief Executive Officer

Accepted and agreed:

/s/ David Farrell

David Farrell

9


GRAPHIC

Exhibit A

AMENDED AND RESTATED FAIR COMPETITION AGREEMENT

In consideration of the continuation of your employment with GTY Technology Holdings Inc. and/or any of its current or future parents, subsidiaries, affiliates, and/or successors (collectively, the “Company”), and the compensation and other benefits you will receive from the Company (your “Employment”), you agree, intending to be legally bound, as follows:

Acknowledgements and Representations

1.Supplemental Terms. You acknowledge that you have received a separate amended and restated offer letter dated April 15, 2021 (the “Offer Letter”) that sets forth the relevant terms concerning your compensation arrangements with the Company. In the event of any conflict between this Amended and Restated Fair Competition Agreement (this “Agreement”) and the Offer Letter, the terms of the Offer Letter shall govern.

2.Acceptance. You acknowledge that the Company considers the protections provided by this Agreement to be necessary to safeguard its Customer Confidences, Confidential Information, Intellectual Property, Customer relationships (each as defined in this Agreement) and other business interests and is willing to commence or continue your Employment only if you agree to accept the obligations set forth herein.

3.No Conflicting Obligations. You represent that you do not have any contractual or other obligations that would conflict with your Employment by the Company.   In particular, you represent that you are not bound by any agreement, understanding or other obligation (including, without limitation, any non-competition or nonsolicitation agreement) with or to any person or entity that prohibits you from accepting or continuing your Employment by the Company and fully performing all your duties for the Company, except as described on Annex A attached hereto. By executing this Agreement, you hereby acknowledge and confirm that all business activities in which you are currently participating and any boards on which you are serving are listed on Annex A attached hereto, which outside activities are subject to the conditions imposed on such activities in the Offer Letter.

4.Documents and Confidential Information Belonging to Former Employers and Other Third Parties. You also represent that you have not taken or retained, and do not have in your possession, any documents, in either electronic or hard copy form, that belong to any former


employer (which, for purposes of this Agreement, shall include persons, corporations, and other entities for which you have acted as an independent contractor or consultant) and that you will not use or disclose in your work for the Company any trade secrets or confidential information belonging to any former employer or other third party.

At Will Employment and Notice Period

5.At Will Nature of Employment. You acknowledge that neither the Offer Letter nor this Agreement gives you any right to employment or continued employment with the Company and that, unless otherwise provided in another writing executed by an officer of the Company and you, your Employment with the Company shall be at the will of both the Company and you. This means that you are free to resign at any time (subject to providing written notice pursuant to any applicable Notice Period as set forth below), for any or no reason, and, similarly, the Company is free to terminate your Employment at any time, for any or no reason.   Your Employment will continue in effect, however, until terminated by either the Company or you.

6.Notice Period. (a) You understand and agree that you will have access to Customer Confidences, Confidential Information, Intellectual Property and Customer relationships belonging to the Company. You recognize and agree that it is reasonable and necessary for the Company to protect such Customer Confidences, Confidential Information, Intellectual Property, and Customer relationships and to provide a smooth transition if you choose to leave the Company. Consequently, you agree to provide the Company with the following periods of prior notice (the “Notice Period”), in writing, depending on your title at the time of your resignation, of your intent to terminate your employment with the Company: President and Executive Vice Presidents – three (3) months; Senior Vice Presidents – two (2) months; and Vice Presidents and below – one (1) month. If the effective date of your resignation as specified in such notice (the “Resignation Date”) is before the end of the period for which your bonus is determined (the “Bonus Period”), you shall not be entitled to receive any annual or long-term incentive compensation award for that Bonus Period. Additionally, vesting of deferred amounts not yet vested shall cease upon the Resignation Date.

(b)If, at the time you provide notice in accordance with this paragraph 6, you intend or contemplate alternative employment, you also agree to provide sufficient details, in writing, about such alternative employment to allow the Company to meaningfully exercise its rights under this paragraph 6.

(c)During the Notice Period, you will: (i) perform any reasonable duties and responsibilities the Company requests; (ii) devote all of your working time, labor, skill and

2


energies to the business and affairs of the Company; (iii) be paid your base salary; and (iv) be entitled to continue to participate in the Company’s employee benefit plans as provided for herein. After you have given notice of your resignation, the Company may, at any time during the Notice Period and in its sole and absolute discretion, (A) elect to place you on paid leave for all or any part of such Notice Period, subject to applicable law, (B) relieve you of some or all of your duties as an employee of the Company and/or exclude you from its premises or (C) shorten or eliminate the Notice Period and accelerate the date on which your resignation will be effective without any obligation to compensate you for the period between the date that the Company effected the acceleration of the effective date of your resignation and the date on which the Notice Period was originally due to end. For the avoidance of doubt, you agree that the taking of any action described in the preceding sentence by the Company shall not constitute a breach of this Agreement or your Offer Letter.

(d)You further agree that during your employment, including during the Notice Period, whether or not the Company requires you to work during the Notice Period, you will not provide services for any Competitor including, without limitation, engaging in, directly or indirectly, or managing or supervising personnel engaged in, any activity (i) which is similar or substantially related to any activity in which you were engaged, in whole or in part, at the Company; (ii) for which you had direct or indirect managerial or supervisory responsibility at the Company; or (iii) which calls for the application of the same or similar specialized knowledge or skills as those used by you in your activities with the Company. For purposes of this Agreement, a “Competitor” means a business enterprise that (A) engages in any activity, (B) proposes to engage in any activity or (C) owns or controls a significant interest in or is a subsidiary or affiliate of any entity, which, in either case, competes with or proposes to compete with any activity in which the Company is engaged, such as, without limitation, developing and licensing software for federal, state and local governments and governmental agencies.

Duties

7.Nature of Duties. You agree to devote your full working time and efforts to the business and affairs of the Company (which may include service to its affiliates) on a full-time basis and will at all times faithfully, industriously and to the best of your ability, experience and talent, perform all duties that may be required of you. Except to the extent expressly permitted in your Offer Letter, during your Employment, you shall not engage in any other business activities without the prior written consent of the Company. In particular, during your Employment, you agree not to work for or assist, whether or not for profit or personal gain, any Competitor or engage in any business or activity that is similar to or competes directly or indirectly with the Company or is inimical to the best interests of the Company or that would interfere with your ability to work for the Company on a full-time basis.

8.Duty to Disclose Business Opportunities. During your Employment, you shall (a) promptly disclose to the Company all business opportunities that are presented to you in your capacity as an officer or employee of the Company or that are of a similar nature to the Company’s

3


existing business or a type of business the Company is currently developing or considering and (b) not usurp or take advantage of any such business opportunity personally or assist any third party in doing so without first offering such opportunity to the Company.

9.Compliance with Company’s Policies and Practices. During your Employment, you agree to observe and comply with all rules, regulations, policies and practices in effect or adopted by the Company at this time or in the future.

Confidentiality, Non-Disclosure and Intellectual Property

10.Customer Confidences. As used in this Agreement, “Customer” means any person, corporation or other entity (a) for which the Company has performed any services or to which it has sold any products, (b) with which it has engaged in any business activity or (c) from which the Company has actively solicited business or discussed other business arrangements in the year preceding the termination of your Employment. The Company’s Customers expect that the Company will hold all business-related information about them, including the fact that they are doing or are considering doing business with the Company and the specific matters on which they are or may be doing business, in the strictest confidence (“Customer Confidences”). You acknowledge that, during the course of your Employment, you will have access to such Customer Confidences. You also acknowledge and agree that all relationships with Customers that you initiate or develop during your Employment with the Company belong to the Company, not to you personally.

11.Confidential Information. You acknowledge that, during the course of your Employment, you will have access to information relating to the Company’s business that provides the Company with a competitive advantage, is not generally known by persons outside the Company and could not easily be determined or learned by someone outside the Company (“Confidential Information”). Such Confidential Information, whether or not explicitly designated as confidential, includes both written information and information not reduced to writing and includes but is not limited to information about Customers, trade secrets, internal corporate policies and strategies, pricing, financial and sales information, personnel information, forecasts, formulas, compilations, software programs, data, databases, directories, research, client lists and business and marketing plans, and any modifications or enhancements of any of the foregoing. You further agree that if you previously rendered services to the Company (e.g., as an independent contractor or consultant) or otherwise gained knowledge of Customer Confidences and/or Confidential Information (e.g., by executing a Non- Disclosure Agreement prior to your rendering services to the Company in any capacity), your obligations under any such agreement between you and the Company to preserve Customer Confidences and/or Confidential Information shall remain in full force and effect pursuant to the applicable terms contained therein.

12.Duty to Preserve Customer Confidences and Confidential Information. You agree not to use or disclose, without the prior written consent of the Company, both during and after your Employment with the Company, Customer Confidences and Confidential Information, except

4


as may be necessary in the good faith performance of your duties to the Company or as permitted by paragraphs 24 and 25 hereof.

13.Company Documents. You acknowledge that all documents, in hard copy or electronic form, received, created or used by you in connection with your Employment with the Company, other than those relating solely to your personal compensation and benefits, are and will remain the property of the Company. You agree to return and/or cooperate in permanently deleting all such documents (including all copies) promptly upon the termination of your Employment and agree that, during or after your Employment, you will not, under any circumstances, without the written consent of the Company, disclose those documents to anyone outside the Company or use those documents for any purpose other than the advancement of the Company’s interests, or as permitted by paragraphs 24 and 25 hereof. You further understand and agree that you are prohibited from searching for, accessing, viewing, printing, transferring and/or using documents, e-mails, and any other data stored on any of the Company’s computer systems in the absence of a legitimate business need or Company objective, and any such actions or use will be considered unauthorized.

14.Obligation to Return Signed Termination Certificate Upon Termination. Upon termination of your Employment, you will be asked to participate in an exit interview and to sign and deliver a “Termination Certificate,” the form of which is attached hereto as Annex B. If you do not attend an exit interview, you are still obligated to sign and deliver the Termination Certificate. Your failure to sign the Termination Certificate, however, shall not affect any of your obligations under this Agreement.

15.Intellectual Property. (a) You agree to fully and promptly disclose to the Company, without additional compensation, all ideas, original or creative works, inventions, discoveries, computer software or programs, trading strategies, statistical and economic models, improvements, designs, formulae, processes, production methods and technological innovations, whether or not patentable or copyrightable, which, during your Employment with the Company, are made, conceived or created by you, alone or with others, during or after usual working hours, either on or off the job, and which are related to the business of the Company or which relate in any way to the work performed by you for the Company (“Intellectual Property”). You acknowledge that the Company owns all such Intellectual Property rights as works made for hire to the fullest extent of the law. For the avoidance of doubt, you hereby assign to the Company all such Intellectual Property rights in any and all media now known or hereafter developed, along with all existing causes of action, known or unknown.

(b)You agree, at any time during or after your Employment, to sign all papers and do such other acts and things, at the Company’s expense, as the Company deems necessary or desirable and may reasonably require of you to protect the Company’s rights to such Intellectual Property, including applying for, obtaining and enforcing patents or copyrights with respect to such Intellectual Property in any and all domestic and overseas jurisdictions.

5


Restrictive Covenants

16.Nature of Company’s Business. You acknowledge that the Company is engaged in a highly competitive business and that the preservation of its Customer Confidences and Confidential Information is critical to the Company’s continued business success. You also acknowledge that the Company’s relationships with its Customers are extremely valuable and that, by virtue of your Employment with the Company, you have had or may have contact with those Customers and that, if so, you must always act in the best professional manner and are being compensated to develop relationships with Customers on behalf of and for the benefit of the Company. As a result, your engaging in or working for or with any business which is directly or indirectly competitive with the Company would cause the Company great and irreparable harm if not done in strict compliance with this Agreement.

17.Covenant Not to Compete. You acknowledge that the Company is in a highly competitive industry and that your leaving the Company to join a competing business would jeopardize the Company’s Customer Confidences, Confidential Information, Intellectual Property and Customer relationships. Accordingly, you agree that:

(a)Subject to the provisions below, during your Employment with the Company, and for the applicable Non-Compete Period (as defined below), and in consideration for the payments provided for below (excluding, for the avoidance of doubt, any payment in the event your Employment is terminated for Cause (as defined below)), you will not directly or indirectly work for or with, own, invest in, render any service or advice to or otherwise assist (in each case, whether or not for compensation) or act as an officer, director, employee, partner or independent contractor for any Competitor in the United States or any foreign country. You acknowledge that, given the nature of the Company’s business and the geographical market of the Company combined with your role and responsibilities, the geographical area of the United States or any foreign country and the Non-Compete Period are both reasonable.

(b)To the extent that, at the time of the termination of your Employment, you intend to work for or provide services to a Competitor or any arguably competing business, you agree to provide the Company at the time of such termination with at least two weeks’ advance written notice of your intention to do so. You also agree that, should you consider working for any Competitor or arguably competing business at any time during the applicable Non-Compete Period, you will provide the Company with at least two weeks’ advance written notice of your intention to do so. The notices contemplated by this paragraph shall be delivered by you in writing to the attention of the Company’s General Counsel.

(c)If your Employment with the Company is terminated due to your voluntary resignation with the Company following which you are not entitled to receive severance benefits pursuant to the terms of your Offer Letter (i.e., a resignation by you) (a “Non-Severance Resignation”), the Company agrees that the covenant not to compete set forth in paragraph 17(a) shall apply only during the period or periods of the applicable Non-Compete Period that the

6


Company, in its sole discretion, elects to pay you (in accordance with the Company’s normal payroll practices) an amount equal to your regular base salary in effect on the effective date of your voluntary resignation from the Company (the “Non- Compete Payments”). In the event the Company elects to make the Non-Compete Payments, you will be required to execute and not revoke a general release of claims in a standard form utilized by the Company as a condition to your receipt of the Non-Compete Payments. The release must become effective within thirty (30) days following the date the Company notifies you of its intent to enforce the provisions of paragraph 17(a). The Company will determine the timing and duration of the Non- Compete Payments, although in no event will the duration of such payments extend beyond the end of the applicable Non-Compete Period. The Company shall have the right at any time during the Non- Compete Period to invoke its right to make the Non-Compete Payments. For example, if at the time of your termination of Employment, you notify the Company of your intent to go to a non-competing entity, the Company may elect not to make Non-Compete Payments.   If, however, you decide later in the Non-Compete Period to go to a Competitor, you must notify the Company in accordance with paragraph 17(b) above, and the Company shall then have the right to elect to make the Non-Compete Payments for a period lasting no longer than the remainder of the Non-Compete Period. In any instance where the Company has the right to elect to make the Non-Compete Payments, it must do so within fifteen (15) business days of the Company’s receipt of your written notice of your intent to resign or your intent to go to a competing entity, as the case may be. If during any period(s) the Company is making Non-Compete Payments, you perform services for and receive compensation from a non- competing entity, you shall notify the Company of such compensation, and the Company shall be entitled to offset such amounts against the Non-Compete Payments.

(d)If your Employment is terminated by the Company for Cause, the terms of paragraph 17(a) will apply for the duration of the applicable Non-Compete Period and you shall not be entitled to any Non-Compete Payments. For purposes of this Agreement, “Cause” means (i) in the case where your Offer Letter defines “Cause” (or words of like import), “Cause” as defined under your Offer Letter and (ii) if “Cause” (or words of like import) is not defined in your Offer Letter, “Cause” means (A) your violation of any written policies or procedures of the Company (including, without limitation, policies related to sexual harassment), (B) your indictment, conviction of, or plea of guilty or nolo contendere to, a felony or a crime involving moral turpitude, (C) your willful or grossly negligent breach of your duties, (D) any act of fraud, embezzlement or other similar dishonest conduct, (E) any act or omission that the Company determines could have a material adverse effect on the Company, including without limitation, its reputation, business interests or financial condition, (F) your failure to follow the lawful and reasonable directives of the Chief Executive Officer or other employee of the Company to whom you report, or (G) your breach of any written agreement between you and the Company or any of its affiliates.

(e)For purposes of this Agreement, the Non-Compete Period means: (i) if your employment is terminated by the Company without Cause or you resign for Good Reason, the period of time during which you are entitled to receive severance payments from the Company as set forth in your Offer Letter; (ii) if your employment is terminated by the Company for Cause, six (6) months from the effective date of your termination; and (iii) in the event of a Non-Severance

7


Resignation, not more than six (6) months from the effective date of such resignation.

18.Non-Solicitation of Customers.   You acknowledge that, by virtue of your Employment by the Company, you have gained or will gain knowledge of the identity, characteristics and preferences of the Company’s Customers, among other Customer Confidences and Confidential Information, and that you would inevitably have to draw on such information if you were to solicit or service the Company’s Customers on behalf of a Competitor. Accordingly, you agree that during your Employment by the Company (including during any applicable Notice Period), and for twelve (12) months following the termination of that Employment for any reason, (the “Restricted Period”), you will not, on your own behalf or behalf of anyone else, directly or indirectly, solicit the business of, or direct tailored advertisements to, actual or prospective Customers of the Company (a) as to which you performed services or had direct contact, or (b) as to which you had access to Customer Confidences or Confidential Information during the course of your Employment by the Company. You further agree that during the Restricted Period, you will not provide services that are the same as or similar to those provided by the Company or encourage or assist any person or entity in competition with the Company to solicit, service, or direct tailored advertisements to any actual or prospective Customer of the Company covered by the previous sentence of this section, or otherwise seek to encourage or induce any such Customer to cease doing business with, or reduce the extent of its business dealings with, the Company. The prohibitions contained in this section shall not, however, apply to any Customers you developed without any substantial assistance from the Company, provided you so demonstrate in writing during your Employment with the Company.

19.Non-Solicitation of Employees. You also agree that, during the Restricted Period, you will not, directly or indirectly, solicit, hire or seek to hire (whether on your own behalf or on behalf of some other person or entity) any person who is at that time (or was during the prior six (6) months) an employee, consultant, independent contractor, representative or other agent of the Company. Nor will you during the Restricted Period, directly or indirectly, on your own behalf or on behalf of any other person, entity or organization, induce or encourage any employee, consultant, independent contractor, representative or other agent of the Company to terminate or reduce his or her employment or other business relationship or affiliation with the Company.   Nor will you directly or indirectly assist any third party in doing what you yourself are prohibited from doing under this paragraph.

20.Non-Disparagement.   Except as otherwise permitted by this Agreement or applicable law, you agree that during your Employment with the Company and at all times thereafter you will not make disparaging or defamatory comments regarding the Company or its owners, members, directors, officers, employees, shareholders, agents, representatives or others with whom the Company has a business relationship as of the date of termination of your Employment or make any public statements that are intended to, or can reasonably expected to, damage the reputations of any of such entities or persons.

21.Tolling. In the event that you violate any of the preceding provisions of the Restrictive Covenants sections of this Agreement, the time periods set forth in those sections shall

8


be extended for the period of time you remain in violation of the provisions.

Arbitration

22.(a) It is understood and agreed between the parties hereto that any and all claims, grievances, demands, controversies, causes of action or disputes of any nature whatsoever (including, but not limited to, tort and contract claims, and claims based upon any law, statute, order, or regulation) arising out of, in connection with, or in relation to (i) the interpretation, performance or breach of this Agreement, (ii) Employee’s employment by the Company, (iii) the termination of Employee’s employment with the Company, and (iv) the arbitrability of any claims under or relating to this Agreement, shall be resolved by final and binding arbitration. This agreement to arbitrate expressly includes, but is not limited to, claims under Title VII of the Civil Rights Act of 1964, as amended, the Age Discrimination in Employment Act of 1967, as amended, the Americans with Disabilities Act of 1990, as amended, Section 1981 of the Civil Rights Act of 1866, the Family and Medical Leave Act, as amended, the Employee Retirement Income Security Act, as amended, the Fair Labor Standards Act, as amended, and any similar federal, state, local or municipal law, statute or regulation.

(b)The forum for any arbitration under this Agreement shall be final and binding arbitration before under the auspices of JAMS in New York, NY.

(c)The arbitration shall be conducted in accordance with the then-existing JAMS Employment Rules and Procedures, except to the extent such rules conflict with the procedures set forth in this paragraph, in which case these procedures shall govern. Any such arbitration shall be before one arbitrator. The parties shall select a mutually acceptable retired judge from the panel of arbitrators serving with any of JAMS’s offices, but in the event the parties cannot agree on an arbitrator, the Administrator of JAMS shall appoint a retired judge from such panels (the arbitrator so selected or appointed, the “Arbitrator”). The Arbitrator shall render an award and a written, reasoned opinion in support thereof. The Arbitrator shall have power and authority to award any appropriate remedy (in law or equity) or judgment that could be awarded by a court of law in Colorado, and, upon good cause shown, the Arbitrator shall afford the parties adequate discovery, including deposition discovery.

(d)The dispute resolution process shall be strictly confidential. Neither party shall disclose the existence, content, or results of any arbitration hereunder without the prior written consent of all parties, except as required by applicable law. Except as provided herein, the Federal Arbitration Act shall govern the interpretation, enforcement and all proceedings pursuant to this Agreement. The Arbitrator and/or arbitration panel shall be bound by and shall strictly enforce the terms of this paragraph 22 and may not limit, expand or otherwise modify its terms. The Arbitrator and/or arbitration panel shall make a good faith effort to apply the substantive law (and the law of remedies, if applicable) of the State of Colorado, or federal law, or both, as applicable, without reference to conflicts of laws provisions. The Arbitrator and/or arbitration panel shall be bound to honor claims of privilege or work- product doctrine recognized at law, but

9


the Arbitrator and/or arbitration panel shall have the discretion to determine whether any such claim of privilege or work-product doctrine applies. The award rendered shall be final and binding upon the parties, and judgment upon the award may be entered in any court having jurisdiction thereof.

(e)Claims must be brought by either you or the Company in your or its individual capacity, not as plaintiffs or class members in any purported class or collective proceeding, and the arbitrator shall not have the power to hear the arbitration as a class or collective action. To the maximum extent permitted by law, both you and the Company waive the right to bring, maintain, participate in, or receive money from any class, collective or representative proceeding. The parties intend this arbitration provision to be valid, enforceable, irrevocable and construed as broadly as possible.

(f)Each party shall bear its own fees and expenses with respect to this dispute resolution process and any litigation related thereto and the parties shall share equally all fees and expenses, in accordance with the JAMS Employment Rules and Procedures, unless prohibited by applicable law.

Other Terms

23.In the twelve (12) months following the termination of your Employment with the Company, in the event you seek or obtain employment or another business affiliation with any person or entity other than the Company, you agree to provide that person or entity with a copy of this Agreement. You also agree to notify the Company in writing, as far in advance as is reasonably practicable, of the details of such employment or business affiliation. You also agree that the Company may provide a copy of this Agreement to any such person or entity.

24.Nothing in this Agreement restricts or prohibits you from initiating communications directly with, responding to any inquiries from, providing testimony before, providing confidential information to, reporting possible violations of law or regulation to, or from filing a claim or assisting with an investigation directly with a self-regulatory authority or a government agency or entity, including without limitation, the U.S. Securities and Exchange Commission or the Financial Industry Regulatory Authority, (collectively, the “Regulators”), or from making other disclosures that are protected under the whistleblower provisions of federal, state, or local law or regulation. You do not need the prior authorization of the Company to engage in conduct protected by this paragraph, and you do need to notify the Company that you have engaged in such conduct. This Agreement does not limit your right to receive an award from any Regulator that provides awards for providing information relating to a potential violation of the law.

25.Pursuant to the Defend Trade Secrets Act of 2016, non-compliance with the confidentiality provisions of this Agreement shall not subject you to criminal or civil liability under

10


any Federal or State trade secret law for the disclosure of a Company trade secret: (i) in confidence to a Federal, State or local government official, either directly or indirectly, or to an attorney in confidence solely for the purpose of reporting or investigating a suspected violation of law; (ii) in a complaint or other document filed in a lawsuit or other proceeding, provided that any complaint or document containing the trade secret is filed under seal; or (iii) to an attorney representing you in a lawsuit for retaliation by the Company for reporting a suspected violation of law or to use the trade secret information in that court proceeding, provided that any document containing the trade secret is filed under seal and you do not disclose the trade secret, except pursuant to court order.

26.You acknowledge that the restrictions contained in this Agreement are fair, reasonable and necessary for the protection of the legitimate business interests of the Company, and that, in the event of any actual or threatened breach by you, the Company will suffer serious, irreparable and substantial harm to its business and interests, the extent of which may be difficult to determine and impossible to fully remedy by an action at law for momentary damages. You therefore consent to the entry of a restraining order, preliminary injunction or other preliminary, provisional or permanent court order to enforce this Agreement and expressly waive any security that might otherwise be required in connection with such relief, and you further agree that the dispute resolution process set forth in paragraph 22 of this Agreement in no law limits the Company’s right to obtain any preliminary, provision or permanent relief as may be necessary to protect the Company’s rights and interests. You also agree that any request for such relief by the Company shall be in addition and without prejudice to any claim for monetary damages which the Company might elect to assert. In the event you violate any provision of this Agreement, the Company shall be entitled to recover all costs and expenses of enforcement, including reasonable attorneys’ fees.

27.You agree defend, indemnify and hold the Company harmless from and against any and all losses, claims, causes of action, liabilities, damages, costs and expenses (including attorney’s fees) suffered or incurred by the Company as a result of any violation or threatened violation of any of your representations, warranties, covenants or undertakings set forth in this Agreement. In the event of litigation arising from or related to the terms of this Agreement, the prevailing party shall be entitled to recover its reasonable attorneys’ fees and other expenses.

28.If any provision of this Agreement is held to be unenforceable by a court or other decision-maker, the remaining provisions shall be enforced to the maximum extent possible. If a court or other decision-maker should determine that any portion of this Agreement is overbroad or unreasonable, such provision shall be given effect to the maximum extent possible by narrowing or enforcing in part that aspect of the provision found overbroad or unreasonable.

29.This Agreement represents the entire agreement of the parties with respect to the subject matter covered, supersedes any and all prior written or oral agreements including, but not limited to, the Fair Competition Agreement dated September 18, 2018, and cannot be modified except in a writing signed by both parties. The waiver by any party to this Agreement of a breach of any of the provisions of this Agreement shall not operate or be construed as a waiver of any subsequent or simultaneous breach.

11


30.This Agreement shall be binding upon and shall inure to the benefit of the Company and its successors and assigns. Neither a formal assignment nor notice to you shall be required. This Agreement shall be binding upon you and your heirs, executors, administrators and legal representatives. However, your duties and obligations hereunder are personal and shall not be assignable or delegable by you in any manner whatsoever.

31.This Agreement shall be construed in accordance with the laws of the State of Colorado, without regard to the state’s principles of conflict of laws.

32.Any notice required or permitted to be given under this Agreement shall be in writing and sent by both email and certified mail, return receipt requested. If the notice is from you to the Company, it shall be sent to the General Counsel of the Company. If sent by the Company to you, such notice shall be sent to your last known email and home addresses.

33.This Agreement may be executed by fax or email and/or in multiple counterparts, each of which shall be deemed an original.

34.The parties waive the right to a jury trial to the maximum extent permitted by law.

35.You acknowledge that you understand the terms and conditions set forth in this Agreement and have had adequate time to consider whether to agree to them and to consult a lawyer or other advisor of your choice if you wish to do so.

(Signature page follows)

12


IN WITNESS WHEREOF, the parties have executed this Agreement as of this 15th day of April, 2021.

THE COMPANY

By:

/s/ TJ Parass

Printed Name:

TJ Parass

Title:

Chief Financial Officer

EMPLOYEE

By:

/s/ David Farrell

Printed Name:

David Farrell

13


ANNEX A

Description of Current Outside Business Activities or Board Service

Chrysalis Public Services LLC – this is a company that receives income from rental properties and Elevate Interval Fitness LLC investment / management activities. My duties include filing monthly sales tax reports, which is approximately 15 minutes per month.

Elevate Interval Fitness LLC – I serve as a passive investor in 2 fitness facilities located in Washington DC/northern Virginia. I do not have formal duties for this company but receive income on the investment.

Infineum Properties, LLC – I serve as a passive investor in real estate related activities.


ANNEX B

TERMINATION CERTIFICATE

The undersigned hereby certifies as follows:

1.When I signed the Amended and Restated Fair Competition Agreement dated as of April 15, 2021 (the “Agreement”), I read and understood the terms contained therein. I have now reviewed the Agreement again as part of my exit interview, and I fully understand the terms thereof and my continuing obligations thereunder, including my obligations (a) not to use for personal benefit or disclose to others any Confidential Information (as defined in the Agreement), and (b) to assign to the Company all rights (if any) that I may have acquired in any Intellectual Property (as defined in the Agreement).

2.I have fully complied with the terms of the Agreement, including the return of any documents and other tangible materials of any nature pertaining to my employment by GTY Technology Holdings Inc. (the “Company”).

3.I recognize that the unauthorized taking of any Confidential Information or Intellectual Property is a crime, and that any unauthorized taking of Confidential Information or Intellectual Property may also result in civil liability.

4.The Company may notify my new employer of (a) the general nature or subject matter of the Confidential Information (without actually disclosing such Confidential Information) to which I had access while employed by the Company, and (b) my continuing obligations under the Agreement to keep such Confidential Information in confidence, and not to disclose or use such Confidential Information without the Company’s prior written consent.

5.Attached hereto is a complete list of all Intellectual Property which, under the terms of the Agreement, I have assigned to the Company. If no such list is attached, I represent that during my employment I did not make, conceive, reduce to practice or develop, either alone or jointly with others, any Intellectual Property.

6.I understand and acknowledge that should I fail to comply with my obligations under the Agreement, the Company shall have, in addition to a claim for damages, the right to obtain an injunction prohibiting me from disclosing Confidential Information to a third party or using any Intellectual Property.

Employee Signature:

Witnessed by:

Print Name:

David Farrell

Print Name:

Date:

Date:


Exhibit 10.2

GRAPHIC

GTY Technology Holdings Inc.

April 29, 2021

John Curran

Re:Amended and Restated Offer of Employment

Dear John:

On behalf of GTY Technology Holdings Inc. (together with its successors, the "Company" ), I am pleased to offer you the amended and restated terms and conditions of your employment with the Company in the position of Executive Vice President and Chief Financial Officer.

The terms that will apply to your continuing employment with the Company are as follows:

1.

Position and Duties. Commencing on April 29, 2021 (the “Effective Date”), you will be employed by the Company hereunder on a full-time basis as the Company's Executive Vice President and Chief Financial Officer, reporting to the Chief Executive Officer of the Company (the "Company CEO" ).

You agree to perform the duties and responsibilities of your position, and such other duties and responsibilities as shall from time to time be mutually agreed upon between you and the Company CEO. You agree that, while employed by the Company, you will devote your full business time and your best efforts, business judgment, skill and knowledge exclusively to the advancement of the business and interests of the Company and its subsidiaries; provided, however, you will be permitted to (i) engage in charitable and civic activities and (ii) manage your personal and family financial matters, in each case, to the extent such activities do not individually or in the aggregate interfere with your duties and responsibilities to the Company or create any actual or potential conflict of interests with the Company's business.

2.

Base Salary and Annual Bonus. During your employment with the Company, you will receive an initial base salary of $400,000, less applicable tax and other withholdings and deductions required by law, payable in accordance with the Company's payroll practices in effect from time to time. Your base salary will be subject to periodic review by the Compensation Committee (the " Committee") of the Company' s Board of Directors (the "Board").

For each calendar year of your employment, you will be eligible to receive an annual cash incentive bonus (the " Annual Bonus") of 50% of your Base Salary. The Annual Bonus will be subject to pro-ration for any period of employment of less than a full calendar year. The Annual Bonus will be subject to the achievement of performance goals established by the Committee. The actual amount of the Annual Bonus, if any, which may be in excess of the target amount if achievement exceeds performance goals will be determined in good


faith by the Committee. You must be employed by the Company on the day that the Annual Bonus (if any) for a calendar year is paid in order to earn and receive such Annual Bonus. Any earned Annual Bonus shall be subject to standard payroll deductions and withholdings and paid no later than March 15th of the year following the calendar year to which the Annual Bonus relates.

3.

Equity Compensation. You will, subject to approval by the Committee, be granted an equity award under the GTY Technology Holdings Inc. Amended and Restated 2019 Omnibus Incentive Plan (the "Incentive Plan" ) and continuing employment with the Company, be granted the following equity awards pursuant to the terms and conditions of an award agreement and the Incentive Plan (the “Equity Awards”):

a.

Time-Based Restricted Stock Units.

·

On April 30, 2021, 70,000 time-based restricted stock units vesting 25% on December 31, 2021 and 75% on December 31, 2022.

·

On or before December 31, 2021, 30,000 time-based restricted stock units vesting in three equal installments on February 19, 2022; February 19, 2023; and February 19, 2024.

·

On or before December 31, 2022, 30,000 time-based restricted stock units vesting in three equal installments on February 19, 2023; February 19, 2024; and February 19, 2025.

·

On or before December 31, 2023 and the end of each subsequent year, time-based restricted stock units with a fair market value (as defined in the Incentive Plan, Fair Market Value) of $150,000 on the date of grant, rounded up to avoid a grant of fractional shares, vesting in three equal installments on February 19 of each subsequent year.

b.

Performance-Based Restricted Stock Units.

·

On or before December 31, 2021, 55,000 performance-based restricted stock units vesting in three equal installments on February 19 of each subsequent year subject to the achievement of performance goals established by the Committee.

·

On or before December 31, 2022, 55,000 performance-based restricted stock units vesting in three equal installments on February 19 of each subsequent year subject to the achievement of performance goals established by the Committee.

·

On or before December 31, 2023 and the end of each subsequent year, performance-based restricted stock units with a Fair Market Value of $275,000 on the date of grant, rounded up to avoid a grant of fractional shares, vesting in three equal installments on February 19 of each subsequent year subject to the achievement of performance goals established by the Committee.

c.

Long-Term Incentive Plan.

·

On or before December 31, 2022, a grant of performance-based restricted stock units with a Fair Market Value of $2,000,000 on the date of grant, rounded up to

2


avoid a grant of fractional shares, vesting in three equal installments on February 19 of each subsequent year subject to the achievement of performance goals established by the Committee related to revenue and shareholder value (the “2022 Long-Term Incentive Grant”).

·

On or before December 31, 2024, a grant of performance-based restricted stock units with a Fair Market Value of $2,000,000 on the date of grant, rounded up to avoid a grant of fractional shares, vesting in three equal installments on February 19 of each subsequent year subject to the achievement of performance goals established by the Committee related to revenue and shareholder value.

4.

Benefit Plans and Programs. You will be eligible to participate in the Company' s benefits and benefits plans and programs in effect from time to time, subject to the terms of any and all plan documents. The Company reserves the right, in its sole discretion, to amend, change or discontinue, in whole or in part, any and all of its benefits and/or benefit plans and programs, at any time for any reason . The Company will reimburse you for all reasonable business expenses you incur in the performance of your duties, subject to the terms of the Company' s expense reimbursement policies in effect from time to time applicable to senior executives. You will be entitled to paid vacation in accordance with the Company's policies. The Company will provide you with substantially the same director and officer insurance coverage that the Company provides senior executives.

5.

At-Will Employment. Your employment with the Company shall, at all times, be on an "at­ will" basis. This means that your employment is not for a fixed term or definite period. Rather, your employment can be terminated at any time, for any or no reason, with or without cause or notice, and you may resign at any time with or without reason, subject to any notice you are required to provide pursuant to the terms of the Fair Competition Agreement between you and the Company. The at-will nature of the employment relationship cannot be changed except in a separate, individualized, written agreement signed by you and the Company.

6.

Termination. In the event your employment with the Company terminates for any reason, the Company will pay you (i) unpaid base salary through the termination date, payable in accordance with the Company's payroll practices, (ii) unreimbursed business expenses, payable in accordance with and subject to the terms of the Company's expense reimbursement policies and (iii) any vested non-forfeitable amounts owing or accrued as of the termination date under the Company's benefit plans or programs in which you participated (collectively, the "Accrued Benefits").

Without otherwise limiting the "at-will" nature of your employment, in the event your employment is terminated at any time by the Company without "Cause" (as defined below) (excluding, for avoidance of doubt, a termination due to your death or Disability) or you resign for "Good Reason" (as defined below), then the Company shall provide you the following payments and benefits (the "Severance Benefits"): (1) an amount equal to the sum of (x) 1.5 times your then current base salary plus (y) 1.5 times of your then current target Annual Bonus, with such amount payable in substantially equal installments over the 18-month period following the date of your termination (the "Severance Period"); (2)

3


provided you timely elect and remain eligible for coverage pursuant to Part 6 of Title I of ERISA, or similar state law (collectively, "COBRA"), payment or reimbursement to you of an amount equal to the full monthly premium for COBRA continuation coverage under the Company's medical plans as in effect on the date of your termination with respect to the level of coverage in effect for you and your eligible dependents as of the date of your termination, on a monthly basis on the first business day of the calendar month next following the calendar month in which the applicable COBRA premiums were paid, with respect to the period from the date of your termination until the earlier of (x) the end of the Severance Period and (y) the date you become eligible for continued coverage under a subsequent employer' s health plan; and (3) any unvested or partially vested Equity Awards shall become fully vested; provided, that, notwithstanding the foregoing, the Equity Awards referenced in Section 3.c. (Long Term-Incentive Plan) shall vest only if and to the extent that they would have vested within six months following the date on which your employment is terminated by the Company without “Cause” or by you for “Good Reason”.

If you resign without “Good Reason” after December 31, 2021 and within 12 months of the Effective Date, then (i) 50% of the 2022 Long-Term Incentive Grant will vest three months after the date on which your employment with GTY terminates as a result of such resignation (the “Separation Date”) and (ii) 50% of the 2022 Long-Term Incentive Grant will vest six months after the Separation Date.

Notwithstanding anything herein to the contrary, you will not be entitled to receive the Severance Benefits or any other payment or benefit triggered upon termination of employment (other than the Accrued Benefits) unless, within 30 days following the termination date, you, or in the event of your death or Disability, your legal representatives, have executed and not revoked a general release of claims in a standard form utilized by the Company (the " Release"). The Severance Benefits shall be paid or commence on the first payroll period following the date the Release becomes effective and the vesting of the Equity Awards if and as provided in this Section 3 shall occur on such date (the "Payment and Vesting Date"), provided that if the period during which you may deliver the Release spans two calendar years, the Payment and Vesting Date shall be no earlier than January 1 of the second calendar year.

For purposes of this offer letter, " Cause" shall mean: (i) a willful act of dishonesty by you in connection with the performance of your duties as an employee; (ii) your conviction of, indictment for, or plea of guilty or nolo contendere to, (x) a felony or (y) any other crime involving fraud , embezzlement or moral turpitude or a material violation of federal or state law that has had or is reasonably likely to have a detrimental effect on the Company's reputation or business; (iii) your gross misconduct in the performance of your duties as an employee; (iv) your intentional or grossly negligent unauthorized use or disclosure of any Confidential Information or Intellectual Property (each as defined in the Fair Competition Agreement); (v) your material breach of any obligations under any written agreement between you and the Company, including, without limitation, the Fair Competition Agreement, if such breach is not remedied by you within thirty (30) days after the Company provides you with notice thereof; (vi) your material breach of any material Company policy generally applicable to Company employees, including but not limited to those relating to

4


insider trading or sexual harassment, if such breach is not remedied by you within thirty (30) days after the Company provides you with notice thereof; or (vii) your willful refusal to follow the lawful directives of the Company CEO, if such refusal is not remedied by you within thirty (30) days after the Company provides you with notice thereof.

For purposes of this offer letter, "Good Reason" shall mean your resignation after one of the following conditions initially has come into existence without your written consent: (i) a material diminution in your base salary or target Annual Bonus opportunity; (ii) a material diminution in your duties as Chief Financial Officer; or (iii) a requirement that you report to any officer of the Company other than the Chief Executive Officer. A resignation for Good Reason will not be deemed to have occurred unless you give the Company written notice of the condition within 90 days after the condition initially comes into existence, the Company fails to remedy the condition within 30 days after receiving your written notice and you actually resign your employment within 60 days following the expiration of the Company' s cure period.

7.

Fair Competition Agreement. As a material inducement for the Company to agree to enter into an employment relationship with you on the terms set forth herein, you agree to execute and comply with the Fair Competition Agreement attached hereto as Exhibit A.

8.

Company Policies and Procedures. Your employment will be subject to the Company ' s policies and procedures (whether as currently existing or to be established in the future), as they may be amended, changed or discontinued at any time and such other rules and regulations as may be adopted or amended in the Company' s sole discretion.

9.

Section 409A. The Severance Benefits and other payments under this offer letter triggered on a termination of employment shall begin only after the date of your "separation from service" (determined as set forth below) , which occurs on or after date of the termination of your employment, and shall be subject to the provisions of this Section 9. The intent of the parties is that payments and benefits under this offer letter comply with, or are exempt from, Section 409A of the Internal Revenue Code of 1986, as amended (the "Code"), and the regulations and guidance promulgated thereunder (collectively, " Section 409A") and, accordingly, to the maximum extent permitted , this offer letter shall be interpreted to be in compliance therewith. For purposes of Section 409A, your right to receive any installment payments pursuant to this offer letter will be treated as a right to receive a series of separate payments . Neither the Company nor you shall have the right to accelerate or defer the delivery of any such payments except to the extent specifically permitted or required by Section 409A.

If, as of the date of your "separation from service" from the Company, you are not a "specified employee" (within the meaning of Section 409A), then each installment of the severance payments shall be made on the dates and terms set forth in this offer letter.

If, as of the date of your "separation from service" from the Company, you are a "specified employee" (within the meaning of Section 409A), then: (i) each installment of the Severance Benefits that, in accordance with the dates and terms set forth in this offer letter,

5


will in all circumstances, regardless of when the "separation from service " occurs, be paid within the short-term deferral period (as defined  in Section  409A) shall  be treated as a "short-term deferral" within the meaning of Treasury Regulation Section 1.409A-l(b)(4) to the maximum extent permissible under Section 409A and shall be paid on the dates and terms set forth in this offer letter; and (ii) each installment of the Severance Benefits that is not described in clause (i) above and that would , absent this clause (ii) , be paid within the six-month period following your " separation from service" from the Company shall not be paid until the date that is six months and one day after such " separation from service" (or, if earlier , your death) , with any such installments that are required to be delayed being accumulated during the six-month period and paid in a lump sum on the date that is six months and one day following your " separation from service " and any subsequent installments , if any, being paid in accordance with the dates and terms set forth in this offer letter ; provided, however , that the preceding provisions  of this clause (ii) shall not apply to any installment  of the Severance Benefits if and to the maximum extent that that such installment is deemed to be paid under a separation pay plan that does not provide for a deferral of compensation by reason of the application of Treasury Regulation l.409A-l(b)(9)(iii) (relating to separation pay upon an involuntary separation from service). Any installments that qualify for the exception under Treasury Regulation Section l.409A-l(b)(9)(iii) must be paid no later than the last day of your second taxable year following the taxable year in which the " separation from service" occurs.

The determination of whether and when your "separation from service" from the Company has occurred shall  be made in a manner consistent  with , and based  on the presumptions  set forth in,   Treasury   Regulation    Section   l.409A-1(h) .   Solely   for   purposes   of   this   paragraph, " Company " shall include all persons with whom the Company would be considered a single employer under Section 414(b) and 414(c) of the Code.

All reimbursements and in-kind benefits provided under this offer letter shall be made or provided in accordance with the requirements of Section 409A to the extent that such reimbursements or in-kind benefits are subject to Section 409A, including, where applicable, the requirements that (1) any reimbursement is for expenses incurred during your lifetime (or during a shorter period of time specified in this offer letter), (2) the amount of expenses eligible for reimbursement during a calendar year may not affect the expenses eligible for reimbursement in any other calendar year, (3) the  reimbursement  of any eligible expense will be made on  or before the last  day  of the calendar year following the year in which the expense is incurred, and (4) the right to reimbursement is not subject to set off or liquidation or exchange for any other benefit.

Notwithstanding any other provision of this offer letter, the Company makes no representation or warranty and shall have no liability to you or to any other person if any provisions of this offer letter are determined to constitute deferred compensation  subject to Section 409A but do not satisfy an exemption from, or the conditions of, that section. If either you or the Company reasonably determines that any payment to you will violate Section 409A, you and the Company agree to use reasonable best efforts to restructure the

6


payment in a manner that is either exempt from or compliant with Section 409A to the extent that the restructuring is consistent with the original economic intent of the parties . You and the Company agree to execute any and all amendments to this offer letter (or any other applicable agreement) that are consistent with the original economic intent of the parties and promote compliance with the distribution provisions of Section 409A in an effort to avoid or minimize , to the  extent allowable by law , the tax (and any interest  or  penalties  thereon)  associated  with  Section 409A. If it is determined that a payment to you was (or may be) made in violation of Section 409A, the Company will cooperate, to the extent commercially reasonable , with any effort by you to mitigate the tax consequences of such violation, including cooperation with your participation in any IRS voluntary compliance program or other correction procedure under Section 409A that may be available to you; provided, that such  correction  is consistent with the commercial intent of the parties hereunder ; provided, further, that in no event shall the Company be obligated to incur any material cost in connection with its obligations under this sentence.

10.

Section 280G. Notwithstanding any other provision of this letter or any other plan, arrangement or agreement to the contrary, if any of the payments or benefits provided or to be provided by the Company or any of its affiliates to you or for your benefit pursuant to the terms of this letter or otherwise ("Covered Payments") constitute "parachute payments" within the meaning of Section  280G of the Code, and would, but for this paragraph be subject to the excise tax imposed under Section 4999 of the Code (or any successor provision thereto) or any similar tax imposed by state or local law or any interest or penalties with respect to such taxes (collectively, the "Excise Tax"), then the Covered Payments shall be reduced (but not below zero) to the minimum extent necessary to ensure that no portion of the Covered Payments is subject to the Excise Tax. Any such reduction shall be made by the Company in its sole discretion consistent with the requirements of Section 409A. Any determination required under this paragraph, including whether any payments or benefits are parachute payments , shall be made by the Company in its sole discretion. You shall provide the Company with such information and documents as the Company may reasonably request in order to make a determination  under this paragraph.  The Company's determinations shall be final and binding on the Company and you.

11.

Notices.  All  notices or other communications required or  permitted  to be given under this offer letter shall be in writing and shall be deemed to have been duly given when delivered personally or one business day after being sent by a nationally recognized overnight delivery service , charges prepaid . Notices also may be given electronically via PDF and by email and shall be effective on the date transmitted if confirmed within 48 hours thereafter by a signed original sent in the manner provided in the preceding sentence.  Notice to you shall be sent to your most recent residence and  personal  email  address on file with the  Company .  Notice to the Company shall be sent to the Company email address of the Chief Executive Officer.

12.

Entire Agreement; Miscellaneous. This offer letter, together  with  the Incentive Plan, any equity award agreements  referenced  herein  and the Fair Competition Agreement, constitutes the entire agreement and understanding between the parties as to the subject matter herein and supersedes all prior or contemporaneous agreements whether written or

7


oral including, but not limited to, the employment letter agreement dated July 29, 2019, as amended, and the Fair Competition Agreement dated July 29, 2019. The terms of this offer letter may only be modified in a specific writing signed by you and an authorized representative of the Company. The invalidity or unenforceability of any  provision  or provisions of this offer letter will not affect the validity or enforceability of any other provision hereof, which will remain in full force and effect. Any disputes arising out of or related to this offer letter or your employment with the Company will be subject to the dispute resolution provisions in the Fair Competition Agreement, and this offer letter shall be governed by and construed in accordance with the governing law provision set forth in the Fair Competition Agreement.   In the event of any conflict between any of the terms in this offer letter and the terms of any other agreement between you and the Company, the terms of this offer letter will control.   By entering into this offer letter and commencing employment with the Company, you represent that you are not bound by any employment contract, restrictive covenant or other restriction that prevents you from entering into employment with or carrying out your responsibilities for the Company, or which is in any way inconsistent with this offer letter. This offer letter is binding on and may be enforced by the Company and its successors and assigns and is binding on and may be enforced by you and your heirs and legal representatives. In addition, the Company may assign this offer letter or any and all rights , duties and obligations hereunder to any subsidiary of the Company; provided that the Company hereby unconditionally guarantees full payment of any payment obligations hereunder in the event of such assignment: provided further that any payment made by any such assignee shall offset any payment obligation of the Company. This offer letter may be executed in any number of counterparts, all of which taken together shall constitute one instrument. Execution and delivery of this offer letter by facsimile or other electronic signature is legal, valid and binding for all purposes.

[Remainder of page intentionally left blank]

8


We are very excited about your continued employment with the Company and I anticipate that you will make many more important contributions to the Company and its strategic mission. Please acknowledge your acceptance of this offer by returning a signed copy of this offer letter.

Very truly yours,

GTY Technology Holdings Inc.

By:

/s/ TJ Parass

Name:

TJ Parass

Title:

Chief Executive Officer

Accepted and agreed:

/s/ John Curran

John Curran

9


GRAPHIC

Exhibit A

FAIR COMPETITION AGREEMENT

In consideration of the continuation of your employment with GTY Technology Holdings Inc. and/or any of its current or future parents, subsidiaries, affiliates, and/or successors (collectively, the “Company”), and the compensation and other benefits you will receive from the Company (your “Employment”), you agree, intending to be legally bound, as follows:

Acknowledgements and Representations

1.Supplemental Terms.  You acknowledge that you have received a separate amended and restated offer letter dated April 29, 2021 (the “Offer Letter”) that sets forth the relevant terms concerning your compensation arrangements with the Company.  In the event of any conflict between this Fair Competition Agreement (this “Agreement”) and the Offer Letter, the terms of the Offer Letter shall govern.

2.Acceptance.  You acknowledge that the Company considers the protections provided by this Agreement to be necessary to safeguard its Customer Confidences, Confidential Information, Intellectual Property, Customer relationships (each as defined in this Agreement) and other business interests and is willing to commence your Employment only if you agree to accept the obligations set forth herein.

3.No Conflicting Obligations.  You represent that you do not have any contractual or other obligations that would conflict with your Employment by the Company.  In particular, you represent that you are not bound by any agreement, understanding or other obligation (including, without limitation, any non-competition or nonsolicitation agreement) with or to any person or entity that prohibits you from accepting or continuing your Employment by the Company and fully performing all your duties for the Company, except as described on Annex A attached hereto.  By executing this Agreement, you hereby acknowledge and confirm that all business activities in which you are currently participating and any boards on which you are serving are listed on Annex A attached hereto, which outside activities are subject to the conditions imposed on such activities in the Offer Letter.

4.Documents and Confidential Information Belonging to Former Employers and Other Third Parties.  You also represent that you have not taken or retained, and do not have in your possession, any documents, in either electronic or hard copy form, that belong to any former employer (which, for purposes of this Agreement, shall include persons, corporations, and other entities for which you have acted as an independent contractor or consultant) and that you will not use or disclose in your work for the Company any trade secrets or confidential information belonging to any former employer or other third party.

At Will Employment and Notice Period

5.At Will Nature of Employment.  You acknowledge that neither the Offer Letter nor this Agreement gives you any right to employment or continued employment with the Company and that, unless otherwise provided in another writing executed by an officer of the Company and you, your Employment with the Company shall be at the will of both the Company and you.  This


means that you are free to resign at any time (subject to providing written notice pursuant to any applicable Notice Period as set forth below), for any or no reason, and, similarly, the Company is free to terminate your Employment at any time, for any or no reason.  Your Employment will continue in effect, however, until terminated by either the Company or you.

6.Notice Period.  (a) You understand and agree that you will have access to Customer Confidences, Confidential Information, Intellectual Property and Customer relationships belonging to the Company.  You recognize and agree that it is reasonable and necessary for the Company to protect such Customer Confidences, Confidential Information, Intellectual Property, and Customer relationships and to provide a smooth transition if you choose to leave the Company.  Consequently, you agree to provide the Company with three months of prior notice (the “Notice Period”), in writing.  If such notice is provided to the Company prior to the bonus payment date for that year, (i) you shall not be entitled to receive any annual or long-term incentive compensation award for that year and (ii) vesting of deferred amounts not yet vested shall cease upon notice of your intent to terminate your employment.

(b)If, at the time you provide notice in accordance with this paragraph 6, you intend or contemplate alternative employment, you also agree to provide sufficient details, in writing, about such alternative employment to allow the Company to meaningfully exercise its rights under this paragraph 6.

(c)During the Notice Period, you will: (i) perform any reasonable duties and responsibilities the Company requests; (ii) devote all of your working time, labor, skill and energies to the business and affairs of the Company; (iii) be paid your base salary; and (iv) be entitled to continue to participate in the Company’s employee benefit plans as provided for herein.  After you have given notice of your resignation, the Company may, at any time during the Notice Period and in its sole and absolute discretion, (A) elect to place you on paid leave for all or any part of such Notice Period, subject to applicable law, (B) relieve you of some or all of your duties as an employee of the Company and/or exclude you from its premises or (C) shorten or eliminate the Notice Period and accelerate the date on which your resignation will be effective without any obligation to compensate you for the period between the date that the Company effected the acceleration of the effective date of your resignation and the date on which the Notice Period was originally due to end.  For the avoidance of doubt, you agree that the taking of any action described in the preceding sentence by the Company shall not constitute a breach of this Agreement or your Offer Letter.

(d)You further agree that during your Employment, including during the Notice Period, whether or not the Company requires you to work during the Notice Period, you will not provide services for any Competitor including, without limitation, engaging in, directly or indirectly, or managing or supervising personnel engaged in, any activity (i) which is similar or substantially related to any activity in which you were engaged, in whole or in part, at the Company; (ii) for which you had direct or indirect managerial or supervisory responsibility at the Company; or (iii) which calls for the application of the same or similar specialized knowledge or skills as those used by you in your activities with the Company.  For purposes of this Agreement, a “Competitor” means a business enterprise that (A) engages in any activity, (B) proposes to engage in any activity or (C) owns or controls a significant interest in or is a subsidiary or affiliate

2


of any entity, which, in either case, competes with or proposes to compete with any activity in which the Company is engaged, such as, without limitation, developing and licensing software for federal, state and local governments and governmental agencies.

Duties

7.Nature of Duties.  You agree to devote your full working time and efforts to the business and affairs of the Company (which may include service to its affiliates) on a full-time basis and will at all times faithfully, industriously and to the best of your ability, experience and talent, perform all duties that may be required of you.  Except to the extent expressly permitted in your Offer Letter, during your Employment, you shall not engage in any other business activities without the prior written consent of the Company.  In particular, during your Employment, you agree not to work for or assist, whether or not for profit or personal gain, any Competitor or engage in any business or activity that is similar to or competes directly or indirectly with the Company or is inimical to the best interests of the Company or that would interfere with your ability to work for the Company on a full-time basis.

8.Duty to Disclose Business Opportunities.  During your Employment, you shall (a) promptly disclose to the Company all business opportunities that are presented to you in your capacity as an officer or employee of the Company or that are of a similar nature to the Company’s existing business or a type of business the Company is currently developing or considering and (b) not usurp or take advantage of any such business opportunity personally or assist any third party in doing so without first offering such opportunity to the Company.

9.Compliance with Company’s Policies and Practices.  During your Employment, you agree to observe and comply with all rules, regulations, policies and practices in effect or adopted by the Company at this time or in the future.

Confidentiality, Non-Disclosure and Intellectual Property

10.Customer Confidences.  As used in this Agreement, “Customer” means any person, corporation or other entity (a) for which the Company has performed any services or to which it has sold any products, (b) with which it has engaged in any business activity or (c) from which the Company has actively solicited business or discussed other business arrangements in the year preceding the termination of your Employment.  The Company’s Customers expect that the Company will hold all business-related information about them, including the fact that they are doing or are considering doing business with the Company and the specific matters on which they are or may be doing business, in the strictest confidence (“Customer Confidences”).  You acknowledge that, during the course of your Employment, you will have access to such Customer Confidences.  You also acknowledge and agree that all relationships with Customers that you initiate or develop during your Employment with the Company belong to the Company, not to you personally.

11.Confidential Information.  You acknowledge that, during the course of your Employment, you will have access to information relating to the Company’s business that provides the Company with a competitive advantage, is not generally known by persons outside the

3


Company and could not easily be determined or learned by someone outside the Company (“Confidential Information”).  Such Confidential Information, whether or not explicitly designated as confidential, includes both written information and information not reduced to writing and includes but is not limited to information about Customers, trade secrets, internal corporate policies and strategies, pricing, financial and sales information, personnel information, forecasts, formulas, compilations, software programs, data, databases, directories, research, client lists and business and marketing plans, and any modifications or enhancements of any of the foregoing.  You further agree that if you previously rendered services to the Company (e.g., as an independent contractor or consultant) or otherwise gained knowledge of Customer Confidences and/or Confidential Information (e.g., by executing a Non-Disclosure Agreement prior to your rendering services to the Company in any capacity), your obligations under any such agreement between you and the Company to preserve Customer Confidences and/or Confidential Information shall remain in full force and effect pursuant to the applicable terms contained therein.

12.Duty to Preserve Customer Confidences and Confidential Information.  You agree not to use or disclose, without the prior written consent of the Company, both during and after your Employment with the Company, Customer Confidences and Confidential Information, except as may be necessary in the good faith performance of your duties to the Company or as permitted by paragraphs 24 and 25 hereof.

13.Company Documents.  You acknowledge that all documents, in hard copy or electronic form, received, created or used by you in connection with your Employment with the Company, other than those relating solely to your personal compensation and benefits, are and will remain the property of the Company.  You agree to return and/or cooperate in permanently deleting all such documents (including all copies) promptly upon the termination of your Employment and agree that, during or after your Employment, you will not, under any circumstances, without the written consent of the Company, disclose those documents to anyone outside the Company or use those documents for any purpose other than the advancement of the Company’s interests, or as permitted by paragraphs 24 and 25 hereof.  You further understand and agree that you are prohibited from searching for, accessing, viewing, printing, transferring and/or using documents, e-mails, and any other data stored on any of the Company’s computer systems in the absence of a legitimate business need or Company objective, and any such actions or use will be considered unauthorized.

14.Obligation to Return Signed Termination Certificate Upon Termination.  Upon termination of your Employment, you will be asked to participate in an exit interview and to sign and deliver a “Termination Certificate,” the form of which is attached hereto as Annex B.  If you do not attend an exit interview, you are still obligated to sign and deliver the Termination Certificate.  Your failure to sign the Termination Certificate, however, shall not affect any of your obligations under this Agreement.

15.Intellectual Property. (a) You agree to fully and promptly disclose to the Company, without additional compensation, all ideas, original or creative works, inventions, discoveries, computer software or programs, trading strategies, statistical and economic models, improvements, designs, formulae, processes, production methods and technological innovations, whether or not patentable or copyrightable, which, during your Employment with the Company,

4


are made, conceived or created by you, alone or with others, during or after usual working hours, either on or off the job, and which are related to the business of the Company or which relate in any way to the work performed by you for the Company (“Intellectual Property”).  You acknowledge that the Company owns all such Intellectual Property rights as works made for hire to the fullest extent of the law.  For the avoidance of doubt, you hereby assign to the Company all such Intellectual Property rights in any and all media now known or hereafter developed, along with all existing causes of action, known or unknown.

(b) You agree, at any time during or after your Employment, to sign all papers and do such other acts and things, at the Company’s expense, as the Company deems necessary or desirable and may reasonably require of you to protect the Company’s rights to such Intellectual Property, including applying for, obtaining and enforcing patents or copyrights with respect to such Intellectual Property in any and all domestic and overseas jurisdictions.

Restrictive Covenants

16.Nature of Company’s Business.  You acknowledge that the Company is engaged in a highly competitive business and that the preservation of its Customer Confidences and Confidential Information is critical to the Company’s continued business success.  You also acknowledge that the Company’s relationships with its Customers are extremely valuable and that, by virtue of your Employment with the Company, you have had or may have contact with those Customers and that, if so, you must always act in the best professional manner and are being compensated to develop relationships with Customers on behalf of and for the benefit of the Company.  As a result, your engaging in or working for or with any business which is directly or indirectly competitive with the Company would cause the Company great and irreparable harm if not done in strict compliance with this Agreement.

17.Covenant Not to Compete.  You acknowledge that the Company is in a highly competitive industry and that your leaving the Company to join a competing business would jeopardize the Company’s Customer Confidences, Confidential Information, Intellectual Property and Customer relationships.  Accordingly, you agree that:

(a)Subject to the provisions below, during your Employment with the Company, and for the applicable Non-Compete Period (as defined below), and in consideration for the payments provided for below (excluding, for the avoidance of doubt, any payment in the event your Employment is terminated for Cause (as defined below)), you will not directly or indirectly work for or with, own, invest in, render any service or advice to or otherwise assist (in each case, whether or not for compensation) or act as an officer, director, employee, partner or independent contractor for any Competitor in the United States or any foreign country.  You acknowledge that, given the nature of the Company’s business and the geographical market of the Company combined with your role and responsibilities, the geographical area of the United States or any foreign country and the Non-Compete Period are both reasonable.

(b)To the extent that, at the time of the termination of your Employment, you intend to work for or provide services to a Competitor or any arguably competing business, you agree to provide the Company at the time of such termination with at least two weeks’ advance

5


written notice of your intention to do so.  You also agree that, should you consider working for any Competitor or arguably competing business at any time during the applicable Non-Compete Period, you will provide the Company with at least two weeks’ advance written notice of your intention to do so.  The notices contemplated by this paragraph shall be delivered by you in writing to the attention of the Chief Executive Officer of the Company.

(c)If your Employment with the Company is terminated due to your voluntary resignation with the Company following which you are not entitled to receive severance benefits pursuant to the terms of your Offer Letter (i.e., a resignation by you without Good Reason (as defined in the Offer Letter)) (a “Non-Severance Resignation”), the Company agrees that the covenant not to compete set forth in paragraph 17(a) shall apply only during the period or periods of the applicable Non-Compete Period that the Company, in its sole discretion, elects to pay you (in accordance with the Company’s normal payroll practices) an amount equal to your regular base salary in effect on the effective date of your Non-Severance Resignation from the Company (the “Non-Compete Payments”).  In the event the Company elects to make the Non-Compete Payments, you will be required to execute and not revoke a general release of claims in a standard form utilized by the Company as a condition to your receipt of the Non-Compete Payments.  The release must become effective within thirty (30) days following the date the Company notifies you of its intent to enforce the provisions of paragraph 17(a). The Company will determine the timing and duration of the Non-Compete Payments, although in no event will the duration of such payments extend beyond the end of the applicable Non-Compete Period.  The Company shall have the right at any time during the Non-Compete Period to invoke its right to make the Non-Compete Payments.  For example, if at the time of your termination of Employment, you notify the Company of your intent to go to a non-competing entity, the Company may elect not to make Non-Compete Payments.  If, however, you decide later in the Non-Compete Period to go to a Competitor, you must notify the Company in accordance with paragraph 17(b) above, and the Company shall then have the right to elect to make the Non-Compete Payments for a period lasting no longer than the remainder of the Non-Compete Period.  In any instance where the Company has the right to elect to make the Non-Compete Payments, it must do so within fifteen (15) business days of the Company’s receipt of your written notice of your intent to resign or your intent to go to a competing entity, as the case may be.  If during any period(s) the Company is making Non-Compete Payments, you perform services for and receive compensation from a non-competing entity, you shall notify the Company of such compensation, and the Company shall be entitled to offset such amounts against the Non-Compete Payments.

(d)If your Employment is terminated by the Company for Cause (as defined in the Offer Letter), the terms of paragraph 17(a) will apply for the duration of the applicable Non-Compete Period and you shall not be entitled to any Non-Compete Payments.

(e)For purposes of this Agreement, the Non-Compete Period means: (i) if you resign for Good Reason, the period of time during which you are entitled to receive severance payments from the Company as set forth in your Offer Letter, but in no event beyond the period of time permitted by applicable law; (ii) if your employment is terminated by the Company for Cause, six (6) months from the effective date of your termination; and (iii) in the event of a Non-Severance Resignation, not more than six (6) months from the effective date of such resignation.

6


18.Non-Solicitation of Customers.  You acknowledge that, by virtue of your Employment by the Company, you have gained or will gain knowledge of the identity, characteristics and preferences of the Company’s Customers, among other Customer Confidences and Confidential Information, and that you would inevitably have to draw on such information if you were to solicit or service the Company’s Customers on behalf of a Competitor.  Accordingly, you agree that during your Employment by the Company (including during any applicable Notice Period), and for twelve (12) months following the termination of that Employment for any reason (the “Restricted Period”), you will not, on your own behalf or behalf of anyone else, directly or indirectly, solicit the business of, or direct tailored advertisements to, actual or prospective Customers of the Company (a) as to which you performed services or had direct contact, or (b) as to which you had access to Customer Confidences or Confidential Information during the course of your Employment by the Company.  You further agree that during the Restricted Period, you will not provide services that are the same as or similar to those provided by the Company or encourage or assist any person or entity in competition with the Company to solicit, service, or direct tailored advertisements to any actual or prospective Customer of the Company covered by the previous sentence of this section, or otherwise seek to encourage or induce any such Customer to cease doing business with, or reduce the extent of its business dealings with, the Company.  The prohibitions contained in this section shall not, however, apply to any Customers you developed without any substantial assistance from the Company, provided you so demonstrate in writing during your Employment with the Company.

19.Non-Solicitation of Employees.  You also agree that, during the Restricted Period, you will not, directly or indirectly, solicit, hire or seek to hire (whether on your own behalf or on behalf of some other person or entity) any person who is at that time (or was during the prior six (6) months) an employee, consultant, independent contractor, representative or other agent of the Company.  Nor will you during the Restricted Period, directly or indirectly, on your own behalf or on behalf of any other person, entity or organization, induce or encourage any employee, consultant, independent contractor, representative or other agent of the Company to terminate or reduce his or her employment or other business relationship or affiliation with the Company.  Nor will you directly or indirectly assist any third party in doing what you yourself are prohibited from doing under this paragraph.

20.Non-Disparagement.  Except as otherwise permitted by this Agreement or applicable law, you agree that during your Employment with the Company and at all times thereafter you will not make disparaging or defamatory comments regarding the Company or its owners, members, directors, officers, employees, shareholders, agents, representatives or others with whom the Company has a business relationship as of the date of termination of your Employment or make any public statements that are intended to, or can reasonably expected to, damage the reputations of any of such entities or persons.

21.Tolling.  In the event that you violate any of the preceding provisions of the Restrictive Covenants sections of this Agreement, the time periods set forth in those sections shall be extended for the period of time you remain in violation of the provisions.

Arbitration

22.(a) It is understood and agreed between the parties hereto that any and all

7


claims, grievances, demands, controversies, causes of action or disputes of any nature whatsoever (including, but not limited to, tort and contract claims, and claims based upon any law, statute, order, or regulation) arising out of, in connection with, or in relation to (i) the interpretation, performance or breach of this Agreement, (ii) your Employment by the Company, (iii) the termination of your Employment with the Company, and (iv) the arbitrability of any claims under or relating to this Agreement, shall be resolved by final and binding arbitration.  This agreement to arbitrate expressly includes, but is not limited to, claims under Title VII of the Civil Rights Act of 1964, as amended, the Age Discrimination in Employment Act of 1967, as amended, the Americans with Disabilities Act of 1990, as amended, Section 1981 of the Civil Rights Act of 1866, the Family and Medical Leave Act, as amended, the Employee Retirement Income Security Act, as amended, the Fair Labor Standards Act, as amended, and any similar federal, state, local or municipal law, statute or regulation.

(b)The forum for any arbitration under this Agreement shall be final and binding arbitration under the auspices of JAMS in Boston, Massachusetts.

(c)The arbitration shall be conducted in accordance with the then-existing JAMS Employment Rules and Procedures, except to the extent such rules conflict with the procedures set forth in this paragraph, in which case these procedures shall govern.  Any such arbitration shall be before one arbitrator.  The parties shall select a mutually acceptable retired judge from the panel of arbitrators serving with any of JAMS’s offices, but in the event the parties cannot agree on an arbitrator, the Administrator of JAMS shall appoint a retired judge from such panels (the arbitrator so selected or appointed, the “Arbitrator”).  The Arbitrator shall render an award and a written, reasoned opinion in support thereof.  The Arbitrator shall have power and authority to award any appropriate remedy (in law or equity) or judgment that could be awarded by a court of law in the Commonwealth of Massachusetts, and, upon good cause shown, the Arbitrator shall afford the parties adequate discovery, including deposition discovery.

(d)The dispute resolution process shall be strictly confidential.  Neither party shall disclose the existence, content, or results of any arbitration hereunder without the prior written consent of all parties, except as required by applicable law.  Except as provided herein, the Federal Arbitration Act shall govern the interpretation, enforcement and all proceedings pursuant to this Agreement.  The Arbitrator shall be bound by and shall strictly enforce the terms of this paragraph 22 and may not limit, expand or otherwise modify its terms.  The Arbitrator shall make a good faith effort to apply the substantive law (and the law of remedies, if applicable) of the Commonwealth of Massachusetts, or federal law, or both, as applicable, without reference to conflicts of laws provisions.  The Arbitrator shall be bound to honor claims of privilege or work-product doctrine recognized at law, but the Arbitrator shall have the discretion to determine whether any such claim of privilege or work-product doctrine applies.  The award rendered shall be final and binding upon the parties, and judgment upon the award may be entered in any court having jurisdiction thereof.

(e)Claims must be brought by either you or the Company in your or its individual capacity, not as plaintiffs or class members in any purported class or collective proceeding, and the Arbitrator shall not have the power to hear the arbitration as a class or collective action.  To the maximum extent permitted by law, both you and the Company waive the

8


right to bring, maintain, participate in, or receive money from any class, collective or representative proceeding.  The parties intend this arbitration provision to be valid, enforceable, irrevocable and construed as broadly as possible.

(f)Each party shall bear its own fees and expenses with respect to this dispute resolution process and any litigation related thereto and the parties shall share equally all fees and expenses, in accordance with the JAMS Employment Rules and Procedures, unless prohibited by applicable law.

Other Terms

23.In the twelve (12) months following the termination of your Employment with the Company, in the event you seek or obtain employment or another technology company other than the Company, you agree to provide that person or entity with a copy of this Agreement.  You also agree to notify the Company in writing, as far in advance as is reasonably practicable, of the details of such employment or business affiliation.  You also agree that the Company may provide a copy of this Agreement to any such person or entity.

24.Nothing in this Agreement restricts or prohibits you from initiating communications directly with, responding to any inquiries from, providing testimony before, providing Confidential Information to, reporting possible violations of law or regulation to, or from filing a claim or assisting with an investigation directly with a self-regulatory authority or a government agency or entity, including without limitation, the U.S. Securities and Exchange Commission or the Financial Industry Regulatory Authority (collectively, the “Regulators”), or from making other disclosures that are protected under the whistleblower provisions of federal, state, or local law or regulation.  You do not need the prior authorization of the Company to engage in conduct protected by this paragraph, and you do need to notify the Company that you have engaged in such conduct.  This Agreement does not limit your right to receive an award from any Regulator that provides awards for providing information relating to a potential violation of the law.

25.Pursuant to the Defend Trade Secrets Act of 2016, non-compliance with the confidentiality provisions of this Agreement shall not subject you to criminal or civil liability under any Federal or State trade secret law for the disclosure of a Company trade secret: (i) in confidence to a Federal, State or local government official, either directly or indirectly, or to an attorney in confidence solely for the purpose of reporting or investigating a suspected violation of law; (ii) in a complaint or other document filed in a lawsuit or other proceeding, provided that any complaint or document containing the trade secret is filed under seal; or (iii) to an attorney representing you in a lawsuit for retaliation by the Company for reporting a suspected violation of law or to use the trade secret information in that court proceeding, provided that any document containing the trade secret is filed under seal and you do not disclose the trade secret, except pursuant to court order.

26.You acknowledge that the restrictions contained in this Agreement are fair, reasonable and necessary for the protection of the legitimate business interests of the Company, and that, in the event of any actual or threatened breach by you, the Company will suffer serious, irreparable and substantial harm to its business and interests, the extent of which may be difficult

9


to determine and impossible to fully remedy by an action at law for momentary damages.  You therefore consent to the entry of a restraining order, preliminary injunction or other preliminary, provisional or permanent court order to enforce this Agreement and expressly waive any security that might otherwise be required in connection with such relief, and you further agree that the dispute resolution process set forth in paragraph 22 of this Agreement in no way limits the Company’s right to obtain any preliminary, provision or permanent relief as may be necessary to protect the Company’s rights and interests.  You also agree that any request for such relief by the Company shall be in addition and without prejudice to any claim for monetary damages which the Company might elect to assert.  In the event you violate any provision of this Agreement, the Company shall be entitled to recover all costs and expenses of enforcement, including reasonable attorneys’ fees.

27.In the event of litigation arising from or related to the terms of this Agreement, the prevailing party shall be entitled to recover its reasonable attorneys’ fees and other expenses.

28.If any provision of this Agreement is held to be unenforceable by a court or other decision-maker, the remaining provisions shall be enforced to the maximum extent possible.  If a court or other decision-maker should determine that any portion of this Agreement is overbroad or unreasonable, such provision shall be given effect to the maximum extent possible by narrowing or enforcing in part that aspect of the provision found overbroad or unreasonable.

29.This Agreement represents the entire agreement of the parties with respect to the subject matter covered, supersedes any and all prior written or oral agreements including, but not limited to, the Fair Competition Agreement dated July 29, 2019,  and cannot be modified except in a writing signed by both parties.  The waiver by any party to this Agreement of a breach of any of the provisions of this Agreement shall not operate or be construed as a waiver of any subsequent or simultaneous breach.

30.This Agreement shall be binding upon and shall inure to the benefit of the Company and its successors and assigns.  Neither a formal assignment nor notice to you shall be required.  This Agreement shall be binding upon you and your heirs, executors, administrators and legal representatives.  However, your duties and obligations hereunder are personal and shall not be assignable or delegable by you in any manner whatsoever.

31.This Agreement shall be construed in accordance with the laws of the Commonwealth of Massachusetts, without regard to the state’s principles of conflict of laws.

32.Any notice required or permitted to be given under this Agreement shall be in writing and sent by both email and certified mail, return receipt requested.  If the notice is from you to the Company, it shall be sent to the Chief Executive Officer of the Company.  If sent by the Company to you, such notice shall be sent to your last known email and home addresses.

33.This Agreement may be executed by fax or email and/or in multiple counterparts, each of which shall be deemed an original.

34.The parties waive the right to a jury trial to the maximum extent permitted by law.

10


35.You acknowledge that you understand the terms and conditions set forth in this Agreement and have had adequate time to consider whether to agree to them and to consult a lawyer or other advisor of your choice if you wish to do so.

(Signature page follows)

11


IN WITNESS WHEREOF, the parties have executed this Agreement as of this 29th day of April, 2021.

THE COMPANY

By:

/s/ TJ Parass

Printed Name:

TJ Parass

Title:

Chief Executive Officer

EMPLOYEE

By:

/s/ John Curran

Printed Name:

John Curran

12


ANNEX A

Description of Restrictive Agreements

Description of Current Outside Business Activities or Board Service

(Covered activities include: (1) Service on a board of directors similar body such as advisory committee, creditors committee, oversight or management body or investment board of any entity (including charitable, civic, religious, fraternal and other nonprofit organizations, etc.) whether or not compensation is received; (2) Outside securities sales activities, including involvement in private placements or offerings, are prohibited whether or not they involve compensation in any form; and (3) Outside business activities for which any compensation is received.) (Include the name of the outside entity/employer, type of business performed, type and method of compensation (if any), the estimated amount of time to be dedicated to the outside activity and any potential conflicts of interest that may arise). Note: Certain outside business activities and board service will require the approval of the Company’s Board of Directors or other individuals or committees.


ANNEX B

TERMINATION CERTIFICATE

The undersigned hereby certifies as follows:

1.When I signed the Fair Competition Agreement dated as of April 29, 2021 (the “Agreement”), I read and understood the terms contained therein. I have now reviewed the Agreement again as part of my exit interview, and I fully understand the terms thereof and my continuing obligations thereunder, including my obligations (a) not to use for personal benefit or disclose to others any Confidential Information (as defined in the Agreement), and (b) to assign to the Company all rights (if any) that I may have acquired in any Intellectual Property (as defined in the Agreement).

2.I have fully complied with the terms of the Agreement, including the return of any documents and other tangible materials of any nature pertaining to my employment by GTY Technology Holdings Inc. (the “Company”).

3.I recognize that the unauthorized taking of any Confidential Information or Intellectual Property is a crime, and that any unauthorized taking of Confidential Information or Intellectual Property may also result in civil liability.

4.The Company may notify my new employer of (a) the general nature or subject matter of the Confidential Information (without actually disclosing such Confidential Information) to which I had access while employed by the Company, and (b) my continuing obligations under the Agreement to keep such Confidential Information in confidence, and not to disclose or use such Confidential Information without the Company’s prior written consent.

5.Attached hereto is a complete list of all Intellectual Property which, under the terms of the Agreement, I have assigned to the Company. If no such list is attached, I represent that during my employment I did not make, conceive, reduce to practice or develop, either alone or jointly with others, any Intellectual Property.

6.I understand and acknowledge that should I fail to comply with my obligations under the Agreement, the Company shall have, in addition to a claim for damages, the right to obtain an injunction prohibiting me from disclosing Confidential Information to a third party or using any Intellectual Property.

Employee Signature:

    

Witnessed by:

Print Name:

John Curran

Print Name:

Date:

Date:


EXHIBIT 31.1

CERTIFICATION

PURSUANT TO RULE 13a-14 AND 15d-14

UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED

I, TJ Parass, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q for the quarter ended March 31, 2021 of GTY Technology Holdings Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15(d)-15(f)) for the registrant and have:

a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepting accounting principles;

c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.

Date: May 13, 2021

By:

/s/ TJ Parass

 

 

TJ Parass

 

 

Chief Executive Officer (Principal Executive Officer)


EXHIBIT 31.2

CERTIFICATION

PURSUANT TO RULE 13a-14 AND 15d-14

UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED

I, John Curran, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q for the quarter ended March 31, 2021 of GTY Technology Holdings Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15(d)-15(f)) for the registrant and have:

a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepting accounting principles;

c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.

Date: May 13, 2021

By:

/s/ John Curran

John Curran

Chief Financial Officer (Principal Financial Officer)


EXHIBIT 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. 1350

(SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002)

In connection with the Quarterly Report of GTY Technology Holdings Inc. (the “Company”) on Form 10-Q for the quarter ended March 31, 2021, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, TJ Parass, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

(1)   the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)   the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: May 13, 2021

/s/ TJ Parass

Name:

TJ Parass

Title:

Chief Executive Officer

(Principal Executive Officer)


EXHIBIT 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. 1350

(SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002)

In connection with the Quarterly Report of GTY Technology Holdings Inc. (the “Company”) on Form 10-Q for the quarter ended March 31, 2021, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, John Curran, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

(1)    the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)   the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: May 13, 2021

/s/ John Curran

Name:

John Curran

Title:

Chief Financial Officer

(Principal Financial Officer)